好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | P9 - Poster Session 09

Wednesday 04/17/24
08:00 AM - 09:00 AM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Poster Session
General Neurology, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, 好色先生, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neurocritical Care, Neurohospitalist, Neuromuscular and Clinical Neurophysiology (EMG), Sleep
View the latest research on a variety of topics. Posters are available in-person or online.
0.00 CME credit
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Interactive
Event Timeline
08:00 AM - 09:00 AM MDT Abstract 9-001 - Sleep Apnea 好色先生 for Asian American Communities in West Michigan
Kamalpreet K. Mann, MD
08:00 AM - 09:00 AM MDT Abstract 9-002 - Evaluating Sleep Apnea Risk in Survivors of Intracerebral Hemorrhage in the REDUCE Cohort
Emma S. Peasley
08:00 AM - 09:00 AM MDT Abstract 9-003 - Identification of Cardiovascular Biomarkers in a Rat Model of Obstructive Sleep Apnea
Dong-Ick Shin, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 9-004 - Solriamfetol Improves Cognitive Performance in Preclinical Models of Sleep Apnea and in a Randomized Placebo-controlled Study of Sleep Apnea Participants (SHARP)
Gregory S. Parks, PhD
08:00 AM - 09:00 AM MDT Abstract 9-005 - Sleep Quality, Occupational Stress, and Alcohol Consumption Among Hispanic University Employees: Exploring Complex Relationships and Mediation Effects
Carlos A. Rodríguez Alarcón, MD
08:00 AM - 09:00 AM MDT Abstract 9-006 - Prevalence of Obstructive Sleep Apnea and Insomnia in Neurological Populations
Christian F. Mouchati, MD
08:00 AM - 09:00 AM MDT Abstract 9-007 - Exploring the Relationship Between E-Cigarette Use Patterns and Sleep Quality in College Students
Carlos A. Rodríguez Alarcón, MD
08:00 AM - 09:00 AM MDT Abstract 9-010 - SURWEY Study of Solriamfetol: Initiation, Titration, Safety, Efficacy, and Follow-up Experience for Patients with OSA in Germany
Samantha Floam, DMD
08:00 AM - 09:00 AM MDT Abstract 9-011 - Exposure-Response Modeling to Describe Change in Brain Amyloid Following Lecanemab Administration in Patients with Early Alzheimer’s Disease
Brian A. Willis, PhD
08:00 AM - 09:00 AM MDT Abstract 9-012 - Cereset Research Reduces Symptoms of Stress, Insomnia, and Anxiety in Healthcare Workers: a Randomized Clinical Trial
Charles H. Tegeler, MD
08:00 AM - 09:00 AM MDT Abstract 9-013 - VGL101: An Immunotherapy that Enhances Microglial Survival for Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP)
Abbie Renoux
08:00 AM - 09:00 AM MDT Abstract 9-014 - Recovery After Acute Diesel Exhaust Inhalation Demonstrates Persistent Neuroinflammation and Sex-based Differences in Resolution of Neurotoxicity
Alexandra N. Demetriou
08:00 AM - 09:00 AM MDT Abstract 9-015 - Long-term Cognitive Outcomes of Elderly Patients After Shunt Surgery for Idiopathic Normal Pressure Hydrocephalus (iNPH): A Literature Review
Sean Hanna, MD
08:00 AM - 09:00 AM MDT Abstract 9-017 - Two First Cousins Died of Sporadic Creutzfeldt-Jakob Disease
Ling Ling Rong, MD
08:00 AM - 09:00 AM MDT Abstract 9-018 - Effects of Brexpiprazole on Agitation Associated with Dementia Due to Alzheimer’s Disease: Analysis of Pooled Response Data from Two Phase 3 Fixed-dose Trials
Sanjeda Chumki
08:00 AM - 09:00 AM MDT Abstract 15-001 - Acute Tele-stroke Triage Modalities Do Not Influence Length of Stay
Azima Shaji, MD, MBBS
08:00 AM - 09:00 AM MDT Abstract 15-002 - Inpatient Psychiatry Consultations in Patients Admitted to Neurology
Lahoud Touma, MD
08:00 AM - 09:00 AM MDT Abstract 15-004 - Establishing a Rapid Access Post-hospitalization Neurology Clinic at an Urban Tertiary Care Center
Dan Tong Jia, MD
08:00 AM - 09:00 AM MDT Abstract 3-001 - Non-motor Effects of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study
Harini Sarva, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-002 - The PD-Ballet Study: A World First Randomised Controlled, Single-blinded, Diversity-enabled Trial of Dance Therapy for Parkinson’s
Aleksandra Podlewska, PhD
08:00 AM - 09:00 AM MDT Abstract 3-003 - Quality of Life Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa in People with Parkinson's
Leonard Verhagen Metman, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 3-004 - Safety Profile of IPX203 in Patients Exposed for 12 Months in a Phase 3 Study in PD by Modal Dose Distribution
Ghazal Banisadr, PhD
08:00 AM - 09:00 AM MDT Abstract 3-005 - Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa on Sleep Dysfunction in People with Parkinson's
Robert A. Hauser, MD, MBA, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-006 - Living with Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa for Symptom Management in Advanced Parkinson’s Disease: A Patient Experience Study
Michael Soileau, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-007 - Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study
Claire Henchcliffe, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-008 - Long-term Safety and Tolerability of Foslevodopa/Foscarbidopa for Treatment of Motor Fluctuations in Parkinson’s Disease
Maurizio Facheris, MD, MSc
08:00 AM - 09:00 AM MDT Abstract 3-009 - Design of a Phase 2 Study of Suvecaltamide in Moderate-to-severe Parkinson’s Disease Tremor
Tara Skarpaas
08:00 AM - 09:00 AM MDT Abstract 3-010 - Characterization of Infusion Site Reactions (ISR) with 24-hour Subcutaneous Infusion of ND0612: Findings from an Integrated Safety Database
Rajesh Pahwa, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-011 - The 201 Trial in Untreated Parkinson's Disease
Milton H. Werner
08:00 AM - 09:00 AM MDT Abstract 3-012 - Onset of Efficacy with Continuous, Subcutaneous Levodopa/carbidopa Infusion in Patients with Parkinson’s Disease Experiencing Motor Fluctuations
Nelson F. Lopes
08:00 AM - 09:00 AM MDT Abstract 3-013 - Association of Vitamin B12 and Homocysteine with Parkinson's Disease Progression in Contemporary Trials
Chadwick W. Christine, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 3-014 - Real-time Levodopa Level Monitoring from Capillary Blood in Parkinson’s Disease: A Pilot Study
Katherine Longardner, MD
08:00 AM - 09:00 AM MDT Abstract 3-015 - Learn to Meditate: An Innovative Program Teaching Mind-body Strategies to People with Parkinson’s Disease
Mark Reed
08:00 AM - 09:00 AM MDT Abstract 3-016 - Effects of Prefrontal Repetitive Transcranial Magnetic Stimulation on Executive Function in Veterans with Parkinson’s Disease and Mild Cognitive Impairment
Kalea L. Colletta, DO
08:00 AM - 09:00 AM MDT Abstract 3-017 - Functional and Cognitive Benefits of a Community Tandem Cycling Exercise Intervention on Patients with Parkinson’s Disease and Their Care Partners
Ryan Reyes
08:00 AM - 09:00 AM MDT Abstract 3-018 - Clustered Difference of Gut Microbiome in Helicobacter Pylori Negative and Positive Group Effect on Clinical Motor Symptoms in PD (Helicobacter Pylori-Stool Microbiome or HP-SM Trial)
Wannisa Wongpipathpong, MD
08:00 AM - 09:00 AM MDT Abstract 3-019 - Reductions in OFF Time with ND0612 for People with Parkinson’s Disease Experiencing Motor Fluctuations: Responder-analysis from an Open-label Study
Stuart H. Isaacson, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 12-001 - Acute Treatment of Migraine with Zavegepant Nasal Spray Reduces the Use of Select Analgesics
Samantha Sweeney, Other
08:00 AM - 09:00 AM MDT Abstract 12-002 - The Safety and Efficacy of Dual Calcitonin Gene-related Peptide Therapies for Migraine Treatment
Ho Hyun Lee
08:00 AM - 09:00 AM MDT Abstract 12-003 - Interictal Burden Before Initiating Calcitonin Gene-related Peptide Monoclonal Antibody for Migraine Prevention
Lars Viktrup
08:00 AM - 09:00 AM MDT Abstract 12-004 - A Preliminary Systematic Review and Meta-analysis of Randomized Control Trials of Rimegepant and Zavegepant for Acute Pain Relief from Migraine
Sakina Matcheswalla, MBBS
08:00 AM - 09:00 AM MDT Abstract 12-005 - Comprehensive Analysis of Migraine Burden and Treatment Trends: A Retrospective Cohort Study of Recent Large Multiple Commercial Payer Databases.
Mariya Petrova
08:00 AM - 09:00 AM MDT Abstract 12-006 - Physiologically-based Pharmacokinetic Modeling for Assessment of the Drug-drug Interaction Potential of Zavegepant
David Semel
08:00 AM - 09:00 AM MDT Abstract 12-007 - Treatment with Zavegepant Offers Improvements in Pain Severity Over 48-hours When Compared with Placebo—Post Hoc Results from a Randomized Placebo-controlled Trial (BHV3500-301)
Jessica Cirillo
08:00 AM - 09:00 AM MDT Abstract 12-009 - Are Post-lumbar Puncture Headaches More Common in Patients with Idiopathic Intracranial Hypertension: A Small Tertiary Health Care Retrospective Review
Ricky Paramo
08:00 AM - 09:00 AM MDT Abstract 12-010 - Using Design Thinking to Create a Health System Wide Approach to Addressing Unmet Headache Access
Scott M. Friedenberg, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-001 - Earlier Initiation of Ublituximab Treatment Is Associated with Improved Disability Outcomes Among Treatment Naïve Participants in ULTIMATE I and II
Chris Garner
08:00 AM - 09:00 AM MDT Abstract 6-002 - B-Cell Depletion and Efficacy Outcomes of Ofatumumab Are Consistent Across Different Body Mass Index Categories: Insights from ASCLEPIOS I and II Trials
Patricia K. Coyle, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-003 - Assessing the Impact of Immune Checkpoint Inhibitor Therapy on Clinical and MRI Activity in Patients with Multiple Sclerosis
Saira Afzal, MD
08:00 AM - 09:00 AM MDT Abstract 6-004 - Aggressive Multiple Sclerosis: Clinical Phenotype and Treatment Within a Randomised Clinical Trial of Autologous Haematopoietic Stem Cell Transplantation vs High Efficacy Disease Modifying Treatment
Gavin Brittain, MBBS
08:00 AM - 09:00 AM MDT Abstract 6-005 - Ocrelizumab in Patients With Early-stage RRMS—Results from the Phase IIIb ENSEMBLE Trial and the Matched Real-world NTD MS Registry Cohort
Hans-Peter Hartung, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-006 - Baseline Serum Neurofilament Light Chain Levels Predict Future Disease Activity Irrespective of Race/Ethnicity: Results from the Phase 3 ASCLEPIOS I/II Trials
Jason W. Freeman, MD
08:00 AM - 09:00 AM MDT Abstract 6-007 - Long-term Effect of Ofatumumab on Serum Immunoglobulin Levels in Patients with Relapsing Multiple Sclerosis
Amit Bar-Or, MD, FRCPC
08:00 AM - 09:00 AM MDT Abstract 6-008 - Ofatumumab Reduces Clinical and Radiological Activity in People with Recently Diagnosed Treatment-naive Relapsing Multiple Sclerosis Irrespective of Baseline Serum Neurofilament Light Chain Levels
Gabriel Pardo, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-009 - Comparing the Infectious and Neoplastic Adverse Event Profiles of Ocrelizumab and Cladribine Using the FDA Adverse Event Reporting Database
Nasrin Rahimian, MD
08:00 AM - 09:00 AM MDT Abstract 6-010 - Longer-term Safety and Efficacy of Ofatumumab in People with Relapsing Multiple Sclerosis for Up to 6 Years
Heinz Wiendl, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-011 - Immunoglobulin Level Changes in Patients with Multiple Sclerosis Treated with Anti-CD20 Monoclonal Antibodies
Enrique Alvarez, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 6-012 - The Safety Profile of Fenebrutinib in Patients with Multiple Sclerosis Is Consistent with Those in Previously Studied Autoimmune Indications
Jiwon Oh, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-013 - Changes in Plasma NfL and GFAP in Response to Anti-CD20 Treatment in MS
Robert H. Gross, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-014 - Real-world Effectiveness, Tolerability, and Safety of Ofatumumab at 12-month Follow-up
Carrie M. Hersh, DO, MSc, FAAN
08:00 AM - 09:00 AM MDT Abstract 6-015 - Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis
Tomoko Okamoto
08:00 AM - 09:00 AM MDT Abstract 6-016 - Multiple Sclerosis Disease Breakthrough on B-cell Depleting Therapies: Experience of a Tertiary Academic Medical Center in the Midwest
Chelsie Thompson, DO
08:00 AM - 09:00 AM MDT Abstract 6-017 - Ublituximab Significantly Reduces Radiological Disease Activity at 12 Weeks: Post-hoc analysis of Participants with Highly Active Disease in the ULTIMATE I & II Phase 3 Studies
Anne Gocke, PhD
08:00 AM - 09:00 AM MDT Abstract 6-018 - An Investigation of Myelin Streamline Decomposition of Brain Networks in the SYNERGY Trial
Sara Bosticardo
08:00 AM - 09:00 AM MDT Abstract 7-001 - Women’s Career Development Pilot Program for Neurological Trainees: Design, Implementation, and Evaluation Over Two Years
Maryann Mays, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 7-002 - Advancing Gender Equity in Latin American Neurology Training: Insights for Program Planning
Arantxa N. Sanchez Boluarte, MD, MPH
08:00 AM - 09:00 AM MDT Abstract 7-003 - Creation, Implementation, and Outcomes of a Formative Simulation Course for Promoting Healthy Equity 好色先生 in Neurology: A Pilot Study
Javier Suarez, MD
08:00 AM - 09:00 AM MDT Abstract 7-004 - Waiting on the World to Change: How SDOH Screening Rates Make a Case for New Embedded SDOH 好色先生al Curricula in Neurology Training Programs
Jonathan P. Williams, MD, MSCR
08:00 AM - 09:00 AM MDT Abstract 7-005 - 好色先生 Anti-racism 好色先生 Pilot Program: A Single Academic Center Experience
Maya Gabel, MD
08:00 AM - 09:00 AM MDT Abstract 7-006 - Improving Rural Stroke Processes - A Trainee-driven Approach
Mandi Ellgen, MD
08:00 AM - 09:00 AM MDT Abstract 7-007 - Implementing an Advocacy-based Resident Curriculum in a Neurology Program
Tara Torabi, MD
08:00 AM - 09:00 AM MDT Abstract 1-001 - Shorter Time to Treatment with Diazepam Nasal Spray Is Associated with Faster Seizure Termination: A Subpopulation Analysis
Steven T. Whitworth, PhD
08:00 AM - 09:00 AM MDT Abstract 1-002 - Pharmacokinetics and Tolerability of Single-dose Staccato® Alprazolam in Adolescents with Epilepsy and Population PK Analysis to Support Dose Selection in Adolescents
Steven A. Phillips, MD
08:00 AM - 09:00 AM MDT Abstract 1-003 - Expert Consensus Recommendations on Seizure Emergencies Suitable for Rapid and Early Seizure Termination (REST) and Timing of Intervention
Michael Chez, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 1-004 - An Analysis of Status Epilepticus Treatment in the Emergency Department in Detroit: A Retrospective Review
Jason Liu, MD
08:00 AM - 09:00 AM MDT Abstract 1-005 - Electro-clinical Variables Associated with Clobazam Response in Adults Presenting with Refractory Status Epilepticus: A Retrospective Study
Arichena Ramanathan Manmatharayan, MD
08:00 AM - 09:00 AM MDT Abstract 1-006 - Crossover Study Evaluating the Effect of Seizures on the Absorption of Diazepam from a Buccal Film Formulation in Children with Epilepsy
Stephen Wargacki, Stephanie M. Varjan
08:00 AM - 09:00 AM MDT Abstract 1-007 - Pharmacokinetics of Staccato® Alprazolam in Healthy Adult Participants: Phase 1, Randomized, Placebo-controlled Ethno-bridging Study
Alyssa Jameson, PA
08:00 AM - 09:00 AM MDT Abstract 1-008 - Levetiracetam Initial Dosing for Status Epilepticus Treatment in the Emergency Department
Michael D. Kolesnik, DO
08:00 AM - 09:00 AM MDT Abstract 1-009 - Pulmonary Safety of Staccato® Alprazolam in Healthy Participants and Participants with Mild Asthma: Phase 1, Randomized, Double-blind, Placebo-controlled Trial
Jeanne A. Vander Zanden, PharmD, BCPP
08:00 AM - 09:00 AM MDT Abstract 1-010 - Assessment of Adherence to Status Epilepticus Treatment Guideline at a Single Institution After Initiation of Status Epilepticus Order Set
Jasmine Singh, MD
08:00 AM - 09:00 AM MDT Abstract 1-011 - CNS Penetration of Perampanel: Correlation of Serum to Cerebrospinal Fluid (CSF) Levels of Perampanel
Geetika Bajpai, MBBS
08:00 AM - 09:00 AM MDT Abstract 1-012 - Soticlestat in Vitro Metabolism and Drug-drug Interactions: Comprehensive Investigations Display Minimal Notable Interactions
Lawrence H. Cohen
08:00 AM - 09:00 AM MDT Abstract 1-013 - Proposed Mechanism of Action of Soticlestat as an Antiseizure Medication
Naga V. Pathi Jagannatham, MD
08:00 AM - 09:00 AM MDT Abstract 1-015 - Balancing Life and Risk: Assessing SUDEP Preventive Interventions to Improve Quality of Life: A Systematic Review
Rufida A. Salih, MBBS
08:00 AM - 09:00 AM MDT Abstract 1-016 - Determinants of Health-related Quality of Life of Patients with Focal Epilepsy: A Systematic Literature Review
08:00 AM - 09:00 AM MDT Abstract 4-001 - Acute Symptomatic Seizure Secondary to Takotusbo Cardiomyopathy
Omolara D. Kolawole, MD
08:00 AM - 09:00 AM MDT Abstract 4-003 - Status Epilepticus Mimic: Severe Encephalopathy and Abnormal Movements Associated with Kratom Toxicity
Connor Bluntson, MD
08:00 AM - 09:00 AM MDT Abstract 4-004 - Leukemoid Reaction in the Setting of Status Epilepticus: A Case Report
Joseph Nguyen, DO
08:00 AM - 09:00 AM MDT Abstract 4-005 - Recurrent Aphasia with Encephalopathy as an Initial Presentation of Polycythemia Vera
Nishel Y. Kothari, MBBS
08:00 AM - 09:00 AM MDT Abstract 4-006 - Unusual Case of Recurrent Falls Secondary to Tumefactive Perivascular Spaces
Zahid Iqbal, MD
08:00 AM - 09:00 AM MDT Abstract 4-007 - Severe Thiamine Deficiency Mimicking Guillain Barre Syndrome (GBS) in the Absence of Wernicke’s Encephalopathy in a Young Female with Alcohol Use and Significant Weight Loss
Kyle Kaneko, DO
08:00 AM - 09:00 AM MDT Abstract 4-008 - Isolated Unilateral Hypoglossal Nerve Palsy in a Man with Anterior Cervical Osteophyte
Dhanya Gorty, MBBS
08:00 AM - 09:00 AM MDT Abstract 4-009 - Giant Cell Arteritis with Bilateral Temporal Arteritis and Optic Perineuritis
Hassnain A. Rizvi, DO
08:00 AM - 09:00 AM MDT Abstract 4-010 - A Case Report: Malignant Cerebral Edema as an Anaphylactic Reaction to Intrathecal Contrast from CT Myelography
Omolara D. Kolawole, MD
08:00 AM - 09:00 AM MDT Abstract 4-011 - The Use of Intravenous Thrombolytics in Acute Ischemic Stroke Patients with Unruptured Intracranial Aneurysm: A Systematic Review and Meta Analysis
Hashim Talib Hashim Manea
08:00 AM - 09:00 AM MDT Abstract 4-012 - Retro-odontoid Pseudotumor Mimicking Acute Stroke Symptoms—An Unusual Case Report
Manmeet P. Kaur, MD
08:00 AM - 09:00 AM MDT Abstract 4-013 - Non-alcoholic Wernicke’s Encephalopathy Associated with Hyperemesis Gravidum
Christian Sidebottom, MD
08:00 AM - 09:00 AM MDT Abstract 4-014 - Self-limited Acute Cerebellitis with MRI Correlation Secondary to 5-Fluorouracil
Hassan Imtiaz, MD
08:00 AM - 09:00 AM MDT Abstract 13-001 - Chronic Pain is Common and Associated with Anhedonia and Somatic Symptoms in People with HIV
Ronald J. Ellis, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 13-002 - Diagnosis of HIV-associated Neurocognitive Disorder (HAND) in Latin America: A Scoping Review
Karlos A. Acurio, MD
08:00 AM - 09:00 AM MDT Abstract 13-003 - Optic Neuritis in the Setting of HIV and Syphilis Co-infection: A Case Report
Ajay Menon, MD
08:00 AM - 09:00 AM MDT Abstract 13-005 - A Systemic Review of Neurological Signs, Symptoms, and Neuroimaging Findings of Nipah Virus (NiV) Infection
Carlos L. Vindel, MD
08:00 AM - 09:00 AM MDT Abstract 13-006 - A First in Human Case of Fatal Encephalitis Secondary to Novel Bunyavirus
Sai Varun Bethina, MBBS
08:00 AM - 09:00 AM MDT Abstract 13-007 - A Rare Case of Infectious Immunodeficiency-related Vaccine-derived Rubella Virus Affecting the Central Nervous System
Jacob Jeffrey Esper, DO
08:00 AM - 09:00 AM MDT Abstract 13-008 - Asymmetric Weakness in a Patient Infected with West-Nile Virus; an Atypical Presentation
Aaron Creswell, MS
08:00 AM - 09:00 AM MDT Abstract 13-009 - Epidemiology and Clinical Characteristics of Meningitis Following COVID-19 Vaccinations: A Systematic Review
Mostafa M. Meshref, MD
08:00 AM - 09:00 AM MDT Abstract 13-010 - Rhabdomyolysis in Acute COVID-19 Infection: A Descriptive Outcomes Analysis
Roopa Sharma, MD
08:00 AM - 09:00 AM MDT Abstract 5-001 - Thrombectomy for the Treatment of Large Core Ischemic Strokes: An Updated Systematic Review and Meta-analysis After the Release of the TESLA and TENSION Trials
Mahmoud Dibas, MD
08:00 AM - 09:00 AM MDT Abstract 5-003 - A Case Series of Spontaneous Thrombosis with a Conservative Approach to Posterior Spinal Artery Aneurysm Management
Yasaman Pirahanchi, MD
08:00 AM - 09:00 AM MDT Abstract 5-004 - Right MCA Stroke Presenting with Receptive Amusia
Sungita Kumar, MD
08:00 AM - 09:00 AM MDT Abstract 5-005 - The Art of Finding the Brain’s Construction from the Face: A Report of Contralateral Central-type Facial Palsy from a Medullary Infarction
Fatai M. Akemokwe, MBBS
08:00 AM - 09:00 AM MDT Abstract 5-006 - “Crescent Moon” Sign in Complete Brown-Sequard Syndrome Caused by Spinal Cord Infarction
Daniel Moreno-Zambrano, MD
08:00 AM - 09:00 AM MDT Abstract 5-007 - Successful Use of Intraosseous Tenecteplase in Acute Ischemic Stroke
Sameera Khan, MD
08:00 AM - 09:00 AM MDT Abstract 5-008 - Use of a Non-invasive Central Arterial Pressure Waveform Analysis Device in Stroke Patients – A Feasibility Study
Kasim Qureshi, MD
08:00 AM - 09:00 AM MDT Abstract 5-009 - Recurrence Risk Counseling Following Childhood Stroke
Catherine M. Amlie-Lefond, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 5-010 - Innominate Artery Steal Syndrome Case with Stroke-like Symptoms – A Case Report
Sparshee Naik
08:00 AM - 09:00 AM MDT Abstract 5-011 - Cortical Venous Infarction Presenting as Audio-visual Hallucinations: A Case Presentation
Hamzah Ahmad, DO
08:00 AM - 09:00 AM MDT Abstract 5-012 - Foix-Chavany-Marie Syndrome Case Series
Neeharika Krothapalli, DO
08:00 AM - 09:00 AM MDT Abstract 5-013 - Rare Case of a Delayed WEB Device Collapse in a Large Basilar Apex Aneurysm
Mustafa Mohamed, MD
08:00 AM - 09:00 AM MDT Abstract 5-015 - A Case of Bilateral Strokes Caused by Vasculitic Intracranial Narrowings
Laurence Poirier, MD
08:00 AM - 09:00 AM MDT Abstract 5-016 - Hidden Gems in Pediatric Basilar Artery Dissection: Unveiling Clues Beyond the Imaging Curtain
Ana Maria Roman, MD
08:00 AM - 09:00 AM MDT Abstract 5-017 - Yield of MRI Brain in Acute Nontraumatic Intraparenchymal Hemorrhage: A Retrospective Study
Cattien N. Phan, DO
08:00 AM - 09:00 AM MDT Abstract 5-018 - Intramedullary Spinal Cord Cavernous Malformation Presenting After Strenuous Weightlifting
Muhammad Hussain, MD
08:00 AM - 09:00 AM MDT Abstract 5-019 - Mechanical Thrombectomy Outcomes for Tele-stroke Inter-hospital Transfers vs. Direct Admit Patients
Hamid Ali, MBBS
08:00 AM - 09:00 AM MDT Abstract 5-020 - Factors Predicting the Use of Endovascular Thrombectomy Following Acute Ischemic Stroke in Adults with Chronic Atrial Fibrillation
Prince K. Pekyi-Boateng, MBBS
08:00 AM - 09:00 AM MDT Abstract 5-021 - Age at Time of Stroke Does Not Predict Post-stroke Fatigue
Andrew Persaud, MD
08:00 AM - 09:00 AM MDT Abstract 5-022 - Chiari Network and Eustachian Valves in PFO-related Stroke; Incidental or Pathogenic Finding?
Mohammed Qussay Ali Al-Sabbagh, MD
08:00 AM - 09:00 AM MDT Abstract 5-023 - Implementing Telestroke in the Inpatient Setting: A Qualitative Analysis of Barriers and Facilitators
Samuel Boes
08:00 AM - 09:00 AM MDT Abstract 5-024 - Transient Movement Disorder Following Artery of Percheron Occlusion
Judit Perez Ortiz, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 5-025 - Ischemic Stroke in a Patient with Tricuspid Valve Papillary Fibroelastoma
Sean M. Kelly, MD, PhD
08:00 AM - 09:00 AM MDT Abstract 5-026 - Delayed Cerebral Vasospasm Status Post Meningioma Resection: Case Report
Tyler Kendall, MD
08:00 AM - 09:00 AM MDT Abstract 5-027 - Endovascular Treatment in Acute Ischemic Stroke: A Decade-long Experience from a Single Center in Saudi Arabia
Mohammed Alnafisah, MBBS
08:00 AM - 09:00 AM MDT Abstract 5-028 - Atrioesophageal Fistula Presenting with Intracranial Hemorrhage and Multifocal Bilateral Ischemic Strokes in a Patient with Ehlers-Danlos Syndrome: A Case Report
Hannah Harrison, MD, MBA
08:00 AM - 09:00 AM MDT Abstract 5-030 - A Retrospective Analysis of 100 Consecutive Cases of Stroke in Young Patients with 3 Months Follow-up in a Single Advanced Stroke Center, India
Vijaya Pamidimukkala, Sr., MD
08:00 AM - 09:00 AM MDT Abstract 5-031 - Primordial and Primary Prevention of Ischemic Stroke in Saudi Arabia: A Combination Approach and Evolving Concepts
Bader H. Shirah, MBBS
08:00 AM - 09:00 AM MDT Abstract 5-032 - Moyamoya Disease or Syndrome? - A Case of Uncontrolled Hyperthyroidism
Gowri Anil Peethambar, MBBS
08:00 AM - 09:00 AM MDT Abstract 2-001 - A Case of Headache Progressing to Coma: Atypical Presentation of West Nile Virus Encephalitis
Madeline Russell, MD
08:00 AM - 09:00 AM MDT Abstract 2-002 - Consideration for ICU Admission in New-onset Encephalitis Patients: A Clinical Decision Model Development and Validation Study Based on Two Multicenter Cohorts
Ralph Habis, MD
08:00 AM - 09:00 AM MDT Abstract 2-003 - Herpes Simplex Virus-1 Encephalitis (HSE) and Focal Status Epilepticus in a Patient with Glioblastoma Multiforme (GBM): A Case Report
Taolin Fang, MD
08:00 AM - 09:00 AM MDT Abstract 2-004 - Subarachnoid Cysticercosis, an Unusual Presentation in an Unusual Geographical Context
Luis J. Meneses Quiroz, MD
08:00 AM - 09:00 AM MDT Abstract 11-001 - Beyond Binary: Biomarkers Reveal the Coexistence of Acute Motor Axonal Neuropathy (AMAN) and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) in Guillain-Barré Syndrome
Henk-Andre A. Kroon, MD, MBA
08:00 AM - 09:00 AM MDT Abstract 11-002 - Patient-reported Outcomes with Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% Maintenance Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Colin Anderson-Smits
08:00 AM - 09:00 AM MDT Abstract 11-004 - Antibodies to Ha, Ks, and Zo: Frequency and Characteristics of Antibody-positive Patients in an Unselected Cohort
Kyphuong Luong
08:00 AM - 09:00 AM MDT Abstract 11-005 - Infusion-related Costs for HyQvia Compared to Hizentra in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Faisal Riaz, MD
08:00 AM - 09:00 AM MDT Abstract 11-006 - Clinical Features and Outcome of Guillain–Barre Syndrome in Saudi Arabia: A Multicenter, Retrospective Study
Yousef Aldughaythir, MD
08:00 AM - 09:00 AM MDT Abstract 11-007 - IVIG Effective in Non-Length Dependent Skin Biopsies in Small Fiber Neuropathy with Plexin D1, TS-HDS, and FGFR-3 Antibodies
Lawrence A. Zeidman, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 11-008 - PBC-like Variant of GBS Associated with CAR-T Therapy
Sanita Raju, MD
08:00 AM - 09:00 AM MDT Abstract 11-009 - Brachioradial Pruritus Treatment with Valacyclovir: A Case Series
Anisha Garg, MD
08:00 AM - 09:00 AM MDT Abstract 11-010 - Assessing the Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in the United States: Retrospective Claims Data Analysis
Jennifer Schwinn
08:00 AM - 09:00 AM MDT Abstract 11-012 - Neurofascin-mediated Neuropathy Mimicking Miller-Fisher Syndrome, Displaying a Broader Clinical Spectrum Inclusive of Trigeminal Autonomic Cephalalgias
Manuela Ochoa Urrea, MD
08:00 AM - 09:00 AM MDT Abstract 11-014 - Natural History of Acquired Demyelination in Diabetic Distal Symmetric Polyneuropathy
Roopa Sharma, MD
08:00 AM - 09:00 AM MDT Abstract 11-015 - Recognizing Unmet Need in Chronic Inflammatory Demyelinating Polyneuropathy: Development of a Conceptual Model Characterizing Patient Experiences and Perspectives
Lisa M. Ford, MD, FAAN
08:00 AM - 09:00 AM MDT Abstract 11-017 - Guillain Barre Syndrome in a Patient with Babesiosis: A Case Report
Karandeep S. Bhatti, MBBS
08:00 AM - 09:00 AM MDT Abstract 11-019 - Clinical and Electrophysiological Evaluation of Patients with Thymic Pathology in Terms of Myasthenia Gravis
Beyza A. Arslan, MD
08:00 AM - 09:00 AM MDT Abstract 11-020 - An Interesting ALS-like Presentation from HIV-associated Vacuolar Myelopathy and Syphilis Infection
Elham Askari, MD
08:00 AM - 09:00 AM MDT Abstract 14-001 - Low MOG Expression in Human Thymus, Implications for Central Tolerance Mechanisms in Autoimmunity Against MOG
Osman Corbali, MD
08:00 AM - 09:00 AM MDT Abstract 14-002 - Plasmapheresis Improves Visual Outcomes in Attacks of Optic Neuritis in MOGAD
Max Herman, MD
08:00 AM - 09:00 AM MDT Abstract 14-003 - Isolated Meningitis Is a Unique Clinical Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
Albert Aboseif, DO
08:00 AM - 09:00 AM MDT Abstract 14-004 - Granulocyte Activation and Astrocyte Damage Markers in CSF Differentiate Acute NMOSD and MOGAD from MS
David Leppert, MD
08:00 AM - 09:00 AM MDT Abstract 14-005 - Brain 7T MRI Findings in Patients with Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD)
Michael Levy, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 14-006 - Humoral Signatures of MOG-antibody Associated Disease Track with Age and Disease Activity
Marianna Spatola, MD, PhD, FAAN
08:00 AM - 09:00 AM MDT Abstract 14-007 - Visual Evoked Potentials in MOG Antibody-associated Disease
Chikashi Yano, MD
08:00 AM - 09:00 AM MDT Abstract 14-008 - Transient Monocular Blindness Presenting as Central Retinal Vein Occlusion Secondary to MOGAD Optic Neuritis
Luke Schichtel, DO
08:00 AM - 09:00 AM MDT Abstract 14-009 - Myelin oligodendrocyte Glycoprotein(MOG)IgG antibody associated Meningitis mimicking Tuberculous Meningitis a case series.
Anuraag Gattu
08:00 AM - 09:00 AM MDT Abstract 14-010 - A Case of MOG-AD in an 89-year-old Male
Sarah Kendroud, DO
08:00 AM - 09:00 AM MDT Abstract 14-011 - Adolescent with Unusual Initial Presentation of MOGAD
Emma L. Johnson
08:00 AM - 09:00 AM MDT Abstract 14-012 - Case of Myelin Oligodentrocyte Glycoprotein Antibody-associated Disease (MOGAD) with FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES) in a Pediatric Patient
Michaela Scott, MD
08:00 AM - 09:00 AM MDT Abstract 14-013 - MOGAD Presenting Atypically with Severely Elevated ICP and Meningoencephalitis: Severe Complicated Hospital Course Followed by Return to Near Baseline
Celeste R. Camargo, MD
08:00 AM - 09:00 AM MDT Abstract 14-015 - Peripheral Nervous System Manifestations of MOG Antibody Associated Disease
Pranjal Gupta, MD
08:00 AM - 09:00 AM MDT Abstract 14-016 - Elevated Cerebrospinal Fluid CXCL13 Helps Predict Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody Associated Disorders (MOGAD)
Nishika Karbhari, MD
08:00 AM - 09:00 AM MDT Abstract 14-017 - Atypical Onset and Imaging Characteristics in Non-demyelinating Myelin Oligodendrocyte Glycoprotein Antibody-associated Encephalitis: A Case Report
Neha A. Patel
08:00 AM - 09:00 AM MDT Abstract 14-018 - The Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Single Center Experience
Eva Chava M. Bernfeld, MD
08:00 AM - 09:00 AM MDT Abstract 14-019 - MR Imaging Stabilization of Leukodystrophy-like MOG-associated Disease in a Patient Treated with Rituximab
Ayush Gupta, MD
08:00 AM - 09:00 AM MDT Abstract 14-020 - Isolated Optic Neuritis: Etiology, Characteristics, and Outcomes in a Large Single-center Cohort
Yoji Hoshina, MD
08:00 AM - 09:00 AM MDT Abstract 8-001 - Presentation of Tectal Gliomas: A Rare Explanation for Presumed Congenital Aqueductal Stenosis
Nora R. Jandhyala, MD
08:00 AM - 09:00 AM MDT Abstract 8-002 - Development and Management of Glioma in Patients with Neurofibromatosis Type I
Aarushi Jain
08:00 AM - 09:00 AM MDT Abstract 8-003 - CNS-restricted Relapsed B-lymphoblastic Leukemia Mimicking Guillain-Barré Syndrome
Ethan Edmondson, MD
08:00 AM - 09:00 AM MDT Abstract 8-004 - PTEN Hamartoma Tumor Syndrome Presenting with a Rare Phenotype of Hemimegalencephaly and Intractable Epilepsy
Maryam Haq, MD
08:00 AM - 09:00 AM MDT Abstract 8-005 - Valproic Acid for Treatment of SUNCT Syndrome in a Child
Shantel Apeseche, MD
08:00 AM - 09:00 AM MDT Abstract 8-006 - Hemispheric Havoc: Migraine’s Asymmetry in Cerebral Blood Flow
Abhijit R. Das, MD
08:00 AM - 09:00 AM MDT Abstract 8-007 - Serum Levels of NLRP3 Inflammasome Signaling Protein ASC - A Prognostic Tool in Pediatric Traumatic Brain Injury
Julia Bernal, MD
08:00 AM - 09:00 AM MDT Abstract 8-008 - Case Series: A Review of Three Pediatric Patients with Basal Ganglia Stroke After Minor Head Trauma
Nidhi Ravishankar, MD
Faculty Disclosures
Brian A. Willis, PhD Dr. Willis has received personal compensation for serving as an employee of Eisai, Inc. Dr. Willis has stock in Eli Lilly and Co.
Ziad Hussein No disclosure on file
Sami Omerhoca Sami Omerhoca has nothing to disclose.
Osamu Takenaka No disclosure on file
Natasha Penner No disclosure on file
Sanae Yasuda No disclosure on file
Larisa Reyderman Larisa Reyderman has nothing to disclose.
Catherine Tegeler Ms. Tegeler has nothing to disclose.
Hossam A. Shaltout, PhD Dr. Shaltout has nothing to disclose.
Heidi Munger Clary, MD, MPH Dr. Munger Clary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prova 好色先生. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Munger Clary has stock in HCA Healthcare. Dr. Munger Clary has stock in Eli Lilly. Dr. Munger Clary has stock in Procter and Gamble. Dr. Munger Clary has stock in CVS. Dr. Munger Clary has stock in Johnson and Johnson. Dr. Munger Clary has stock in Novartis. Dr. Munger Clary has stock in Danahauer. The institution of Dr. Munger Clary has received research support from National Institute of Health. The institution of Dr. Munger Clary has received research support from Suzanne Marcus Collins Foundation. The institution of Dr. Munger Clary has received research support from Eysz, Inc. The institution of Dr. Munger Clary has received research support from Department of Defense. The institution of Dr. Munger Clary has received research support from Duke Endowment. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a speaker, Psychiatry Commission member with International League Against Epilepsy. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as a Faculty with J. Kiffin Penry Epilepsy 好色先生 Programs. Dr. Munger Clary has a non-compensated relationship as a advisor, potential site PI with Liva Nova that is relevant to AAN interests or activities.
Dawn Kellar No disclosure on file
Kenzie Brown No disclosure on file
Suzanne Danhauer No disclosure on file
Gregory Russell No disclosure on file
Charles H. Tegeler, MD Dr. Tegeler has nothing to disclose.
David S. Zee, MD Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for florida legal. Dr. Zee has received publishing royalties from a publication relating to health care. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lectuer with u of pittsburg physical therapy. Dr. Zee has received personal compensation in the range of $500-$4,999 for serving as a lecturer with johms hopkins CME.
Christian Mirescu No disclosure on file
David Gray David Gray has received personal compensation for serving as an employee of Vigil. David Gray has received personal compensation for serving as an employee of Inscopix. David Gray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil. David Gray has stock in Vigil.
Marco Colonna No disclosure on file
Frederick Gergits No disclosure on file
Abbie Renoux No disclosure on file
Daria Tchessalova No disclosure on file
Borislav Dejanovic No disclosure on file
Evan Thackaberry Evan Thackaberry has received personal compensation for serving as an employee of Vigil Neuroscience. Evan Thackaberry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bain Capital. Evan Thackaberry has stock in Vigil Neuroscience. Evan Thackaberry has received intellectual property interests from a discovery or technology relating to health care. Evan Thackaberry has received intellectual property interests from a discovery or technology relating to health care.
Kelley Larson No disclosure on file
Dhairyawan Pokalkar, MD, FAAN No disclosure on file
Selena Chen Selena Chen has nothing to disclose.
Kristina Shkirkova Kristina Shkirkova has nothing to disclose.
Hongqiao Zhang No disclosure on file
Krista Lamorie-Foote No disclosure on file
Isaiah Becerra No disclosure on file
Lifu Zhao Lifu Zhao has nothing to disclose.
Max Thorwald Max Thorwald has nothing to disclose.
Jose Godoy Jose Godoy has nothing to disclose.
Wendy Mack No disclosure on file
Constantinos Sioutas Constantinos Sioutas has nothing to disclose.
Caleb E Finch No disclosure on file
Christian Pike The institution of Christian Pike has received research support from Estetra SRL. Christian Pike has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH CSR.
William Mack William Mack has received personal compensation for serving as an employee of NFL. William Mack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Imperative Care. The institution of William Mack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanderbilt University (Stryker study) . William Mack has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. William Mack has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goza and Honnald LLC. William Mack has stock in egret therapeutics. William Mack has stock in Borvo. William Mack has stock in Radical Catheters. William Mack has stock in Vastrax. William Mack has stock in Q'Apel. William Mack has stock in Viseon. William Mack has stock in Stream Biomedical. William Mack has stock in Spartan Micro. William Mack has stock in Endostream. The institution of William Mack has received research support from National Institutes of Health.
Alexandra N. Demetriou Miss Demetriou has nothing to disclose.
No disclosure on file
Sean Hanna, MD Dr. Hanna has nothing to disclose.
Murali Chekuri No disclosure on file
Christopher Carswell No disclosure on file
Anastasia Gonstarova No disclosure on file
Abigail Methley No disclosure on file
Hilary Clare Watt No disclosure on file
Kevin Tsang No disclosure on file
Ronald K. Pearce, MD No disclosure on file
Ling Ling Rong, MD Dr. Rong has nothing to disclose.
Nicholas Lannen, MD Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Nicholas Andersen Nicholas Andersen has nothing to disclose.
Evan Tank Evan Tank has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Jiangyong Min, MD Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation .
Tia Chakraborty, MD Dr. Chakraborty has nothing to disclose.
Aiesha Ahmed, MD, MBA, FAAN Dr. Ahmed has stock in Doximity.
Haichen Yang, MD No disclosure on file
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Audrey Parent No disclosure on file
Osman Corbali, MD Mr. Corbali has nothing to disclose.
Betsy N. Williams, PhD Dr. Williams has received personal compensation for serving as an employee of IQVIA.
Max Herman, MD Dr. Herman has nothing to disclose.
Spencer Hutto, MD Dr. Hutto has nothing to disclose.
Savannah Ngo No disclosure on file
Hang Shi, MD Dr. Shi has nothing to disclose.
Daniel Winkel, MD The institution of Dr. Winkel has received research support from NextSense, Inc.
Tianwen Ma No disclosure on file
Albert Aboseif, DO Dr. Aboseif has received research support from the Eugene & Marcia Applebaum Fellowship Grant.
Nabeela Nathoo, MD, PhD Dr. Nathoo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
John Chen John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. John Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. John Chen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB.
Laura Cacciaguerra, MD, PhD Dr. Cacciaguerra has nothing to disclose.
Nisa Vorasoot, MD Dr. Vorasoot has nothing to disclose.
Samantha Banks, MD Dr. Banks has nothing to disclose.
Jan-Mendelt Tillema, MD Dr. Tillema has nothing to disclose.
Deena Tajfirouz, MD Dr. Tajfirouz has nothing to disclose.
Smathorn Thakolwiboon, MD Dr. Thakolwiboon has nothing to disclose.
Michel Toledano, MD Dr. Toledano has nothing to disclose.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Mitsuru Watanabe Mitsuru Watanabe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharma, Mitsubishi Tanabe Pharma, UCB Japan. Mitsuru Watanabe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharma, Argenx, UCB Japan, Novartis Pharma, Biogen Japan, Mitsubishi Tanabe Pharma, Chugai Pharmaceutical, Viatris, and Daiichi Sankyo. The institution of Mitsuru Watanabe has received research support from Japan. Mitsuru Watanabe has received publishing royalties from a publication relating to health care.
Sabine Schaedelin Sabine Schaedelin has nothing to disclose.
Fredrik L. Piehl, MD, PhD Dr. Piehl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel/Chugai. The institution of Dr. Piehl has received research support from UCB. The institution of Dr. Piehl has received research support from Merck KGaA. Dr. Piehl has received personal compensation in the range of $10,000-$49,999 for serving as a member scientific advisory board with Swedish Medical products Agency.
Roberto Furlan Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Roberto Furlan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Roberto Furlan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Katharina Fink, MD The institution of Dr. Fink has received research support from Swedish Research Council. The institution of Dr. Fink has received research support from ALF. The institution of Dr. Fink has received research support from CMED. Dr. Fink has received personal compensation in the range of $0-$499 for serving as a Lecturer with Swedish MS Society.
Matteo Gastaldi, MD, PhD Dr. Gastaldi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion, Roche, UCB, J&J. The institution of Dr. Gastaldi has received research support from Italian Ministry of Health, FISM, AE alliance.
Pascal Benkert Pascal Benkert has nothing to disclose.
Aleksandra Maceski Aleksandra Maceski has nothing to disclose.
David Leppert, MD Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of GeNeuro. Dr. Leppert has received personal compensation for serving as an employee of Geneuro. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Leppert has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Leppert has received personal compensation in the range of $0-$499 for serving as a Consultant for Orion. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Leppert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Dr. Leppert has stock in Novartis.
Eline Willemse No disclosure on file
Johanna Oechtering The institution of Johanna Oechtering has received research support from Roche. The institution of Johanna Oechtering has received research support from Novartis. The institution of Johanna Oechtering has received research support from Swiss MS society.
Annette Orleth No disclosure on file
Stephanie V. Meier Miss Meier has nothing to disclose.
Daniel Anthony, PhD, MA Dr. Anthony has received personal compensation for serving as an employee of University of Oxford. Dr. Anthony has received personal compensation for serving as an employee of Somerville College Oxford. Dr. Anthony has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Anthony has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuroplast. Dr. Anthony has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Oxomics. The institution of Dr. Anthony has received research support from Numares. The institution of Dr. Anthony has received research support from MRC UK.
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Negar Molazadeh, MD The institution of Dr. Molazadeh has received research support from Genentech, Inc..
Jonathan D. Zurawski, MD The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation. The institution of Dr. Zurawski has received research support from Novartis.
Marcelo Matiello, MD, FAAN Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Matiello has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Matiello has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WoltersKluwer.
Shahamat Tauhid, MD Dr. Tauhid has nothing to disclose.
Michael Levy, MD, PhD, FAAN Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Levy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Levy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Levy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Levy has received research support from National Institutes Health.
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
J Renfroe, MD Dr. Renfroe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage Therapeutics. Dr. Renfroe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Renfroe has received intellectual property interests from a discovery or technology relating to health care.
Marianna Spatola, MD, PhD, FAAN The institution of Dr. Spatola has received research support from Spanish National Health Institute (Carlos III), FIS grant. The institution of Dr. Spatola has received research support from Spanish National Institute of Health - Miguel Servet Grant. The institution of Dr. Spatola has received research support from La Caixa Foundation. The institution of Dr. Spatola has received research support from European Research Coucil.
Omar Chuquisana No disclosure on file
Wonyeong Jung No disclosure on file
Joseph Lopez No disclosure on file
Eva Maria Wendel No disclosure on file
Sudarshini Ramanathan, MBBS, PhD, FRACP Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Ramanathan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Alexion, Novartis. The institution of Dr. Ramanathan has received research support from NHMRC, RACP, University of Sydney.
Christian Keller No disclosure on file
Tim Hahn No disclosure on file
Edgar Meinl No disclosure on file
Markus Reindl, PhD The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
Russell Dale Mr. Dale has nothing to disclose.
Heinz Wiendl, MD, FAAN Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Douglas Lauffenburger No disclosure on file
Kevin Rostasy Kevin Rostasy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Kevin Rostasy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Fabienne Brilot Fabienne Brilot has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Fabienne Brilot has received research support from Novartis.
Galit Alter No disclosure on file
Jan Lünemann, MD Dr. Lünemann has received personal compensation in the range of $0-$499 for serving as a Consultant for Takeda. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ArgenX. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Lünemann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma GmbH. The institution of Dr. Lünemann has received research support from German Research Foundation. The institution of Dr. Lünemann has received research support from French National Research Agency (ANR). The institution of Dr. Lünemann has received research support from National Multiple Sclerosis Society (NMSS). The institution of Dr. Lünemann has received research support from National Institute of Health.
Chikashi Yano, MD Dr. Yano has nothing to disclose.
Tomonori Nakamura No disclosure on file
Eiji Matsuura, MD Dr. Matsuura has nothing to disclose.
Hiroshi Takashima, MD, PhD Dr. Takashima has nothing to disclose.
Yujiro Higuchi No disclosure on file
Yu Hiramatsu No disclosure on file
Yusuke Sakiyama No disclosure on file
Akihiro Hashiguchi No disclosure on file
Masahiro Ando No disclosure on file
Satoshi Nozuma No disclosure on file
Kumiko Michizono No disclosure on file
Keiko Higashi No disclosure on file
Luke Schichtel, DO Dr. Schichtel has nothing to disclose.
Rami Ibrahim, MD Dr. Ibrahim has nothing to disclose.
Xiaojun Zhang, MD Dr. Zhang has nothing to disclose.
Muddana Nikhilesh Muddana Nikhilesh has nothing to disclose.
Sudheeran Kannoth The institution of Sudheeran Kannoth has received research support from ICMR.
Vivek K. Nambiar, DM Dr. Nambiar has nothing to disclose.
sudeep reddy jinna sudeep reddy jinna has nothing to disclose.
Siby Gopinath No disclosure on file
Gopikrishnan Unnikrishnan Gopikrishnan Unnikrishnan has nothing to disclose.
Udit U. Saraf, MD, MBBS Dr. Saraf has nothing to disclose.
Anand Kumar Anandakuttan No disclosure on file
Annamma Mathai Annamma Mathai has nothing to disclose.
Jyothi Leelamaniamma No disclosure on file
Meena Thevarkalam Meena Thevarkalam has nothing to disclose.
Rajender Kandikonda No disclosure on file
Sarah Kendroud, DO Dr. Kendroud has nothing to disclose.
Ahmed Abbas, MD Dr. Abbas has nothing to disclose.
Amro E. AbuShanab, MBBS Dr. AbuShanab has nothing to disclose.
Mahnoor Jadoon, MD Ms. Jadoon has nothing to disclose.
Tracy A. Glauser, MD Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Glauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. The institution of Dr. Glauser has received research support from NIH. Dr. Glauser has received intellectual property interests from a discovery or technology relating to health care. Dr. Glauser has received publishing royalties from a publication relating to health care.
Emma L. Johnson Ms. Johnson has nothing to disclose.
Sagarika Nallu, MD No disclosure on file
Antoniya Marinova Doynova, MD Dr. Marinova Doynova has nothing to disclose.
Natalie Moreo, MD Dr. Moreo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PRIME 好色先生, LLC. Dr. Moreo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Moreo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apollo Medical Communications. The institution of Dr. Moreo has received research support from InnoCare. The institution of Dr. Moreo has received research support from Novartis .
Michaela Scott, MD Dr. Scott has nothing to disclose.
Heidi Duarte No disclosure on file
Sally You, DO Dr. You has nothing to disclose.
Gregory S. Aaen, MD Dr. Aaen has nothing to disclose.
Celeste R. Camargo, MD Dr. Camargo has nothing to disclose.
Amanda R. Spinner, MD Dr. Spinner has nothing to disclose.
Vikram Bhise, MD Dr. Bhise has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharmaceuticals. The institution of Dr. Bhise has received research support from Horizon Blue Cross Blue Shield.
Rachael Cella Ms. Cella has nothing to disclose.
Anvesh Balabhadra, MBBS Dr. Balabhadra has nothing to disclose.
Pranjal Gupta, MD Dr. Gupta has nothing to disclose.
Pritikanta Paul, MD The institution of Dr. Paul has received research support from ZS Associates.
Divyanshu Dubey, MD, FAAN The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Shailee S. Shah, MD Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Shah has received publishing royalties from a publication relating to health care.
Yong Guo Yong Guo has nothing to disclose.
Christopher J. Klein, MD, FAAN Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Yahya J. Abdulrahman Mr. Abdulrahman has nothing to disclose.
Claudia F. Lucchinetti, MD, FAAN The institution of Dr. Lucchinetti has received research support from Biogen Idec. The institution of Dr. Lucchinetti has received research support from NIH/NINDS. The institution of Dr. Lucchinetti has received research support from National Institute of Neurological Disorders and Stroke . The institution of Dr. Lucchinetti has received research support from National Multiple Sclerosis Society. The institution of Dr. Lucchinetti has received research support from National Center for Advancing Translational Sciences. Dr. Lucchinetti has received intellectual property interests from a discovery or technology relating to health care. Dr. Lucchinetti has a non-compensated relationship as a Member with National Institute of Neurological Disorders that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Board of Directors, Association of University Professors of Neurology that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Trustees that is relevant to AAN interests or activities. Dr. Lucchinetti has a non-compensated relationship as a Member with Mayo Clinic Board of Governors that is relevant to AAN interests or activities.
Abhigyan Datta, MD Dr. Datta has nothing to disclose.
Vyanka Redenbaugh, MB BCh BAO Dr. Redenbaugh has nothing to disclose.
Nishika Karbhari, MD Dr. Karbhari has nothing to disclose.
Andrew R. Pachner, MD No disclosure on file
Francesca Gilli No disclosure on file
Krista DiSano No disclosure on file
Andrew D. Smith III, MD Dr. Smith has nothing to disclose.
Nathaniel M. Robbins, MD Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.
Aabishkar Bhattarai, MD Dr. Bhattarai has nothing to disclose.
Samantha De Gannes, MD Dr. De Gannes has nothing to disclose.
Xiang Fang, MD, PhD, FAAN Dr. Fang has nothing to disclose.
Neha A. Patel Miss Patel has nothing to disclose.
Camila Narvaez Caicedo, MD Dr. Narvaez Caicedo has nothing to disclose.
Courtney Mack Miss Mack has nothing to disclose.
Alan Ettinger, MD, FAAN No disclosure on file
Lama Abdel Wahed, MD Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Resident Honorary Speaker with Iowa Neurological Association. Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Author with MedLink. Dr. Abdel Wahed has received personal compensation in the range of $500-$4,999 for serving as a Author with AAN Continuum. Dr. Abdel Wahed has received personal compensation in the range of $0-$499 for serving as a Invited grand round speaker with University of Maryland.
Tracey Cho, MD, FAAN Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
Eva Chava M. Bernfeld, MD Dr. Bernfeld has stock in Roche. Dr. Bernfeld has stock in Siemens. Dr. Bernfeld has stock in Beckton Dickinson. Dr. Bernfeld has stock in Bristol Myers Squibb. Dr. Bernfeld has stock in Linde PLC.. Dr. Bernfeld has stock in Thermo Fisher Scientific. Dr. Bernfeld has stock in United Health Group. An immediate family member of Dr. Bernfeld has stock in Roche. An immediate family member of Dr. Bernfeld has stock in Beckton Dickinson. An immediate family member of Dr. Bernfeld has stock in Bristol Myers Squibb. An immediate family member of Dr. Bernfeld has stock in Thermo Fisher Scientific. An immediate family member of Dr. Bernfeld has stock in Linde PLC. An immediate family member of Dr. Bernfeld has stock in Siemens. An immediate family member of Dr. Bernfeld has stock in Essilorluxotica. An immediate family member of Dr. Bernfeld has stock in Medtronic. An immediate family member of Dr. Bernfeld has stock in Merk and Co. An immediate family member of Dr. Bernfeld has stock in Sanofi. An immediate family member of Dr. Bernfeld has stock in Terumo corp. An immediate family member of Dr. Bernfeld has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Bernfeld has stock in Zoetis. An immediate family member of Dr. Bernfeld has stock in Ge Healthcare technologies. An immediate family member of Dr. Bernfeld has stock in Protalix Biotherapeutics. An immediate family member of Dr. Bernfeld has stock in Teva Pharm Industries. An immediate family member of Dr. Bernfeld has stock in Euroapi SAS. An immediate family member of Dr. Bernfeld has stock in Gillead Sciences. An immediate family member of Dr. Bernfeld has stock in Alcon Ag. An immediate family member of Dr. Bernfeld has stock in Novartis. An immediate family member of Dr. Bernfeld has stock in Bayer. An immediate family member of Dr. Bernfeld has stock in Abbvie. An immediate family member of Dr. Bernfeld has stock in Amgen. An immediate family member of Dr. Bernfeld has stock in Eli Lilly and co. An immediate family member of Dr. Bernfeld has stock in CVS health Corp. An immediate family member of Dr. Bernfeld has stock in Johnson and Johnson.
Ayush Gupta, MD The institution of Dr. Gupta has received research support from Child neurology foundation . The institution of Dr. Gupta has received research support from EMD Serono.
Michael Sweeney, MD Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Sweeney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Yoji Hoshina, MD Dr. Hoshina has nothing to disclose.
Meagan D. Seay, DO Dr. Seay has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various attorneys.
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Sravanthi Vegunta No disclosure on file
Melissa A. Wright, MD Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Tammy L. Smith, MD, PhD Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Smith has received research support from Alexion/AstraZeneca.
Stacey Clardy, MD, PhD, FAAN Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Theresa A. Zesiewicz, MD Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Mahmoud Dibas, MD Mr. Dibas has nothing to disclose.
Mohammad Almajali, MD Dr. Almajali has nothing to disclose.
Malik Ghannam, MBBCh Dr. Ghannam has nothing to disclose.
Abdullah M. Al-Qudah, MD Dr. Al-Qudah has nothing to disclose.
Farid Khasiyev, MD Dr. Khasiyev has nothing to disclose.
Milagros Galecio-Castillo, MD Dr. Galecio-Castillo has nothing to disclose.
Juan A. Vivanco-Suarez, MD Mr. Vivanco-Suarez has nothing to disclose.
Aaron E. Rodriguez-Calienes Dr. Rodriguez-Calienes has nothing to disclose.
Sophie L. Shogren, MD Dr. Shogren has nothing to disclose.
Fawwaz Husam Al Majali, MD Dr. Al Majali has nothing to disclose.
Albert Yoo No disclosure on file
Edgar Samaniego, MD, FAAN Dr. Samaniego has received personal compensation for serving as an employee of University of Iowa. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Terumo Neuro. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rapid Medical. Dr. Samaniego has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for J&J Neuro. Dr. Samaniego has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Metronic. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as a Consultant for iSchemaView. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Society of Neurointerventional Surgery. Dr. Samaniego has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurointerventional Surgery.
Amrou Sarraj, MD Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
Santiago Ortega Gutierrez, MD Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Tuan H. Vu, MD Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ARGENX. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Vu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen (Horizon). Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Vu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Vu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Vu has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Alexion. The institution of Dr. Vu has received research support from RA Pharma/UCB. The institution of Dr. Vu has received research support from Mass Gen Hospital/Healy Platform Study. The institution of Dr. Vu has received research support from ARGENX. The institution of Dr. Vu has received research support from Horizon/Amgen. The institution of Dr. Vu has received research support from Woolsey Pharma. The institution of Dr. Vu has received research support from CSL Behring. The institution of Dr. Vu has received research support from Cartesian Therapeutics. The institution of Dr. Vu has received research support from Janssen/Johnson & Johnson. The institution of Dr. Vu has received research support from Immunovant. The institution of Dr. Vu has received research support from Regeneron. The institution of Dr. Vu has received research support from Dianthus. The institution of Dr. Vu has received research support from COUR.
Abdulhamed H. Ismaiel, Sr., MD Dr. Ismaiel has nothing to disclose.
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Yasaman Pirahanchi, MD Dr. Pirahanchi has nothing to disclose.
Richard A. Rodriguez-Brizuela, DO Dr. Rodriguez-Brizuela has nothing to disclose.
Athena Dao, MD Dr. Dao has nothing to disclose.
Benjamin Atchie No disclosure on file
Ian Kaminsky No disclosure on file
Clifton L. Gooch, MD, FAAN Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Sungita Kumar, MD Dr. Kumar has nothing to disclose.
Sean M. Kelly, MD, PhD Dr. Kelly has nothing to disclose.
Sara K. Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Individual law firms.
Melissa J. Rethana, MD Dr. Rethana has nothing to disclose.
Jennifer R. Molano, MD, FAAN Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Fatai M. Akemokwe, MBBS Dr. Akemokwe has stock in CVS HEALTH CORP. Dr. Akemokwe has stock in LABORATORY CORP AMERICAN HOLDINGS.
Divya Menghani, MBBS Dr. Menghani has nothing to disclose.
Sally V. Mathias, MD, FANA, FAES, FAAN Dr. Mathias has or had stock in Abbvie Inc.Dr. Mathias has received personal compensation in the range of $100,000-$499,999 for serving as a neurologist with Department of Veterans Affairs (VHA).
Christopher C. Muth, MD No disclosure on file
Ricardo E. Martinez, MD Dr. Martinez has nothing to disclose.
Daniel Moreno-Zambrano, MD Dr. Moreno-Zambrano has nothing to disclose.
Rafael Martinez No disclosure on file
Roberto E. Sanchez, MD Dr. Sanchez has nothing to disclose.
Ariol Labrada, MD Dr. Labrada has nothing to disclose.
Christian Hernandez, MD Dr. Hernandez has nothing to disclose.
Jonathan Bundy, MD Dr. Bundy has nothing to disclose.
Sameera Khan, MD Dr. Khan has nothing to disclose.
Aisha M. Ali, MD Dr. Ali has nothing to disclose.
Dusan Stefoski, MD, FAAN No disclosure on file
Kasim Qureshi, MD Dr. Qureshi has nothing to disclose.
Quinton Quagliano No disclosure on file
Taylor R. Anderson, MD Dr. Anderson has nothing to disclose.
Tracy J. Koehler Tracy J. Koehler has nothing to disclose.
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
Philip B. Gorelick, MD, MPH, FAAN Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Roumen D. Balabanov, MD Dr. Balabanov has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Balabanov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Balabanov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Balabanov has received research support from NextCure. The institution of Dr. Balabanov has received research support from Biogen. The institution of Dr. Balabanov has received research support from NINDS.
Elizabeth Anderson, MD Dr. Anderson has nothing to disclose.
Tracie Schroeder Tracie Schroeder has nothing to disclose.
Michael F. Waters, MD, PhD, FAAN Dr. Waters has nothing to disclose.
Daniel Gonzalez, MD Dr. Gonzalez has nothing to disclose.
Supreet Kaur, MD Dr. Kaur has nothing to disclose.
Tiffany Sheehan No disclosure on file
Patricia Teran Patricia Teran has nothing to disclose.
David Z. Wang, DO, FAHA, FAAN Dr. Wang has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Mediwelcome.
Michael Ko, MD No disclosure on file
Sparshee Naik Ms. Naik has nothing to disclose.
Omar M. Al-Janabi, MD, PhD, MSc Dr. Al-Janabi has nothing to disclose.
Bruce M. Coull, MD Dr. Coull has nothing to disclose.
Haitham Dababneh, MD No disclosure on file
Brendan Huang, MD Dr. Huang has nothing to disclose.
Hamzah Ahmad, DO Dr. Ahmad has nothing to disclose.
Simona V. Proteasa, MD Dr. Proteasa has nothing to disclose.
Jina M. Youn, MD, MS Dr. Youn has nothing to disclose.
Neeharika Krothapalli, DO Dr. Krothapalli has nothing to disclose.
Vladislav Zayas, MD Dr. Zayas has nothing to disclose.
Isaac E. Silverman, MD Dr. Silverman has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Various Law Firms.
Mohammed A. Hussain, MD No disclosure on file
Mustafa Mohamed, MD Dr. Mohamed has nothing to disclose.
Melissa Riess, MD Dr. Riess has nothing to disclose.
Sneha Jacob, MD Dr. Jacob has nothing to disclose.
Ankur Garg, MD Dr. Garg has nothing to disclose.
Muhammad Ayub, MD Dr. Ayub has nothing to disclose.
Mohammad A. Sheikh, MBBS Dr. Sheikh has nothing to disclose.
Omar Elsekaily, MBBS Dr. Elsekaily has nothing to disclose.
Prabandh R. Buchhanolla, MBBS Dr. Buchhanolla has nothing to disclose.
Saurabh Kataria, MD Dr. Kataria has nothing to disclose.
Muhammad Khalid, MD Dr. Khalid has nothing to disclose.
Tooba Aslam No disclosure on file
Junaid Ansari, MD Dr. Ansari has nothing to disclose.
Walaa Elsekaily, MBBS Ms. Elsekaily has nothing to disclose.
Himanshu Chokhawala, MD Dr. Chokhawala has nothing to disclose.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Robert Fahed Robert Fahed has nothing to disclose.
Laurence Poirier, MD Dr. Poirier has nothing to disclose.
Michel C. Shamy, MD Dr. Shamy has nothing to disclose.
Brian Drake No disclosure on file
Jay Maxwell No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Patricia Bacus, MD Dr. Bacus has nothing to disclose.
Anna R. Thamann, MD Dr. Thamann has nothing to disclose.
Jeffrey D. Rothstein, MD, PhD Dr. Rothstein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept Therapeutics. Dr. Rothstein has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Pharmaceuticasl. Dr. Rothstein has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ALS Journal. The institution of Dr. Rothstein has received research support from ALSA. The institution of Dr. Rothstein has received research support from MDA. The institution of Dr. Rothstein has received research support from Target ALS. The institution of Dr. Rothstein has received research support from Maryland TEDCO. The institution of Dr. Rothstein has received research support from Dept of Defense. The institution of Dr. Rothstein has received research support from National Insitutes of Health. The institution of Dr. Rothstein has received research support from Corsalex. Dr. Rothstein has received intellectual property interests from a discovery or technology relating to health care.
Cattien N. Phan, DO Dr. Phan has nothing to disclose.
Sanad Batarseh, MD Dr. Batarseh has nothing to disclose.
Syed Hassan Khalid, MD, MBBS Dr. Khalid has nothing to disclose.
Vincent Truong, MD Dr. Truong has nothing to disclose.
Pezhman Roohani, MD No disclosure on file
Liliana Ladner No disclosure on file
Haseeb Goheer Haseeb Goheer has nothing to disclose.
Alexander In No disclosure on file
Muhammad Hussain, MD Dr. Hussain has nothing to disclose.
Chinomso D. Ogumerem, MD Dr. Ogumerem has nothing to disclose.
Chukwudi A. Nwogu, MD Dr. Nwogu has nothing to disclose.
Carlos A. Mora, MD Dr. Mora has nothing to disclose.
Adam Rizvi, MD No disclosure on file
Hamid Ali, MBBS Dr. Ali has nothing to disclose.
Sami Alkasab, MD Dr. Alkasab has nothing to disclose.
Muhammed Amir Essibayi No disclosure on file
Sara A. Mayer, MD No disclosure on file
Prince K. Pekyi-Boateng, MBBS Dr. Pekyi-Boateng has nothing to disclose.
Fiifi Duodu, MD Dr. Duodu has nothing to disclose.
Maya Gabel, MD Dr. Gabel has nothing to disclose.
Nana Boakye Agyeman Badu-Prempeh, MD Ms. Badu-Prempeh has nothing to disclose.
Gregory Atafo No disclosure on file
Daniel Pinkrah No disclosure on file
Ama Dake No disclosure on file
ALVIN TETTEH-QUARSHIE No disclosure on file
Nana Y. Kyei-Frimpong, MD Dr. Kyei-Frimpong has nothing to disclose.
SHER DHILLON No disclosure on file
Balkiranjit Dhillon No disclosure on file
Shaheen Sombans, MBBS Dr. Sombans has nothing to disclose.
Hemamalini Sakthivel No disclosure on file
FNU Aisha No disclosure on file
Kamleshun Ramphul Kamleshun Ramphul has nothing to disclose.
Derick Boateng No disclosure on file
Yaw Adu-Duodu No disclosure on file
Nadege Gilles Ms. Gilles has nothing to disclose.
Steven Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Jeremy Weedon No disclosure on file
Andrew Persaud, MD Mr. Persaud has nothing to disclose.
Anya Turetsky, MD No disclosure on file
Mohammed Qussay Ali Al-Sabbagh, MD Dr. Al-Sabbagh has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD Dr. Eswaradass has nothing to disclose.
Solmaz Ramezani Hashtjin, MD Dr. Ramezani Hashtjin has nothing to disclose.
Samuel Boes Mr. Boes has nothing to disclose.
Christopher Streib, MD Dr. Streib has nothing to disclose.
Maya Peters No disclosure on file
Michael Usher No disclosure on file
Joseph Koopmeiners No disclosure on file
Timothy Beebe The institution of Timothy Beebe has received research support from NIH. The institution of Timothy Beebe has received research support from AHRQ.
Genevieve Melton-Meaux Genevieve Melton-Meaux has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for American college of surgeons. Genevieve Melton-Meaux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Utah, Ohio state university, and Washington University. Genevieve Melton-Meaux has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American medical informatics association. The institution of Genevieve Melton-Meaux has received research support from NIH, AHRQ, PCORI, FDA.
Deborah Pestka Deborah Pestka has nothing to disclose.
Saef Izzy, MD, FAAN The institution of Dr. Izzy has received research support from NINDS. The institution of Dr. Izzy has received research support from The Gillian Reny Stepping Strong Center for Trauma Innovation. Dr. Izzy has received publishing royalties from a publication relating to health care.
Judit Perez Ortiz, MD, PhD Dr. Perez Ortiz has nothing to disclose.
Elizabeth A. Coon, MD, FAAN Dr. Coon has received publishing royalties from a publication relating to health care. Dr. Coon has a non-compensated relationship as a Non-Voting Member of the Board of Directors with UCNS that is relevant to AAN interests or activities.
Zafer Keser, MD Dr. Keser has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Practice Update.
BEN JOHNSON-TESCH No disclosure on file
Johnny Salameh, MD, FAAN Dr. Salameh has nothing to disclose.
Robert Zhang No disclosure on file
Ambika Nayar No disclosure on file
Jennifer Moodie, MD No disclosure on file
Tyler Kendall, MD Dr. Kendall has nothing to disclose.
Brijesh P. Mehta, MD Dr. Mehta has nothing to disclose.
Norman Ajiboye, MD, FAAN Dr. Ajiboye has nothing to disclose.
Sean T. Kenniff, MD Dr. Kenniff has nothing to disclose.
Haris Kamal, MD Dr. Kamal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention .
Zaid F. Alsaaran, Jr., MBBS Dr. Alsaaran has nothing to disclose.
Ismail A. Khatri, MD, MBBS, FAAN Dr. Khatri has nothing to disclose.
Noran Taher, MD Dr. Taher has nothing to disclose.
Nazish Masud No disclosure on file
Mufadhi M. Alshammary, MBBS Dr. Alshammary has nothing to disclose.
Mohammad Ejaz Ahmed No disclosure on file
Jamie L. Starks, MD Dr. Starks has nothing to disclose.
Hannah Harrison, MD, MBA Dr. Harrison has nothing to disclose.
Angel J. Cadena Tejada, MD Dr. Cadena Tejada has nothing to disclose.
Julio A. Chalela, MD Dr. Chalela has nothing to disclose.
Nik Haliza Nik Hassan, MD No disclosure on file
Ahmed Naeem Ahmed Naeem has nothing to disclose.
Hesham Kelani, MD Dr. Kelani has nothing to disclose.
Aliaa Bakr No disclosure on file
Mennatullah Mohamed Eltaras No disclosure on file
David P. Lerner, MD Dr. Lerner has received publishing royalties from a publication relating to health care.
Arthur D. Kay, MD Dr. Kay has nothing to disclose.
Diana Greene-Chandos, MD, FAAN Dr. Greene-Chandos has nothing to disclose.
Lisa R. Merlin, MD, FAAN Dr. Merlin has nothing to disclose.
Vijaya Pamidimukkala, Sr., MD Dr. Pamidimukkala has nothing to disclose.
Naren Polavarapu Naren Polavarapu has nothing to disclose.
Rama Chandra, MBBS Dr. Chandra has nothing to disclose.
Usha Kiran Behera Usha Kiran Behera has nothing to disclose.
Bhargavi Devi Bhargavi Devi has nothing to disclose.
Srinivasa Rao Nutakki No disclosure on file
Uppala Veeramma, MD Dr. Veeramma has nothing to disclose.
Anurag Polavarapu No disclosure on file
Raghava Sarma Polavarapu No disclosure on file
Partha S. Ghosh, MD, FAAN Dr. Ghosh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Ghosh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Bader H. Shirah, MBBS Dr. Shirah has nothing to disclose.
Hussein A. Algahtani, MD, FRACP Dr. Algahtani has nothing to disclose.
Eric J. Sorenson, MD, FAAN The institution of Dr. Sorenson has received research support from Biogen.
Gowri Anil Peethambar, MBBS Dr. Anil Peethambar has nothing to disclose.
Line Abdul Rahman, MD Dr. Abdul Rahman has nothing to disclose.
Yuishin Izumi, MD, PhD No disclosure on file
Nora R. Jandhyala, MD Ms. Jandhyala has nothing to disclose.
Mekka R. Garcia, MD Dr. Garcia has nothing to disclose.
Devorah Segal, MD, PhD Dr. Segal has nothing to disclose.
Ryuji Kaji, MD, FAAN Dr. Kaji has nothing to disclose.
Aarushi Jain Miss Jain has nothing to disclose.
Bailyn Hogue, MD Dr. Hogue has nothing to disclose.
Riley McNeill No disclosure on file
Kaleb H. Yohay, MD Dr. Yohay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Yohay has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Yohay has received publishing royalties from a publication relating to health care.
Ethan Edmondson, MD Dr. Edmondson has nothing to disclose.
Daniel Calame, MD, PhD Dr. Calame has nothing to disclose.
Paisley L. Pauli, DO Ms. Pauli has nothing to disclose.
Jyotinder Punia No disclosure on file
Mirela Cerghet, MD, PhD, FAAN Dr. Cerghet has nothing to disclose.
Maryam Haq, MD Dr. Haq has nothing to disclose.
Nino Kerashvili, MD Dr. Kerashvili has nothing to disclose.
Hassan Imtiaz, MD Dr. Imtiaz has nothing to disclose.
Lonni Schultz, PhD Dr. Schultz has nothing to disclose.
Shantel Apeseche, MD Dr. Apeseche has nothing to disclose.
Stella Chin, MD Dr. Chin has nothing to disclose.
Bridget A. Leone, MD Dr. Leone has nothing to disclose.
Manasa Sudheendra, MBBS Dr. Sudheendra has nothing to disclose.
Karla Salazar, MD Dr. Salazar has nothing to disclose.
Jeffrey Kuerbitz, PhD Dr. Kuerbitz has nothing to disclose.
Ariel M. Lyons-Warren, MD, PhD Dr. Lyons-Warren has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. Dr. Lyons-Warren has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology.
Abhijit R. Das, MD Dr. Das has nothing to disclose.
Stanton B. Elias, MD No disclosure on file
Julia Bernal, MD Ms. Bernal has nothing to disclose.
Maria Mateo No disclosure on file
Juan Pablo De Rivero Vaccari No disclosure on file
Kathryn Swaby No disclosure on file
Charlene Pringle No disclosure on file
Jennifer Coto No disclosure on file
Juan Solano No disclosure on file
Joslyn Gober No disclosure on file
Kevin Wang Kevin Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott Diagnostics. Kevin Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for WorldClass Seminar. Kevin Wang has stock in Gryphon Bio, Inc. Kevin Wang has stock in Owl Therapeutics, LLC. The institution of Kevin Wang has received research support from National Institute of Helath. The institution of Kevin Wang has received research support from US Department of Defense.
Robert Keane No disclosure on file
W. Dalton Dietrich, PhD No disclosure on file
Jennifer Munoz Pareja No disclosure on file
Kourtney Guthrie No disclosure on file
Nidhi Ravishankar, MD Dr. Ravishankar has nothing to disclose.
Arpita Lakhotia, MD, FAAN Dr. Lakhotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Jiong Shi, MD, FAAN Dr. Shi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Lindsay Ross, MD Dr. Ross has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapuetics. Dr. Ross has received publishing royalties from a publication relating to health care.
Catherine Hassett, MD Dr. Hassett has nothing to disclose.
Elizabeth Spurgeon, MD Dr. Spurgeon has nothing to disclose.
Nancy R. Foldvary-Schaefer, DO, FAAN Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Maryann Mays, MD, FAAN Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Naoko Matsui, MD No disclosure on file
Arantxa N. Sanchez Boluarte, MD, MPH Dr. Sanchez Boluarte has received research support from NIH Fogarty International Center .
Joseph R. Zunt, MD The institution of Dr. Zunt has received research support from NIH. Dr. Zunt has received publishing royalties from a publication relating to health care.
Sofía S. Sánchez Boluarte, MD The institution of Dr. Sánchez Boluarte has received research support from NIH.
Javier Suarez, MD Dr. Suarez has nothing to disclose.
Daniel S. Harrison, MD Dr. Harrison has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Glass Health. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Diedrich & Donohue, LLP.
Altaf Saadi, MD, MSc, FAAN The institution of Dr. Saadi has received research support from 好色先生. The institution of Dr. Saadi has received research support from National Science Foundation. The institution of Dr. Saadi has received research support from Russel Sage Foundation. The institution of Dr. Saadi has received research support from National Institute of Health.
J. R. McFaline-Figueroa, MD, PhD The institution of Dr. McFaline-Figueroa has received research support from National Brain Tumor Society. The institution of Dr. McFaline-Figueroa has received research support from National Institutes of Health. The institution of Dr. McFaline-Figueroa has received research support from Robert Wood Johnson Foundation. Dr. McFaline-Figueroa has received publishing royalties from a publication relating to health care. Dr. McFaline-Figueroa has received publishing royalties from a publication relating to health care.
Nuri Jacoby, MD, FAAN Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Jonathan P. Williams, MD, MSCR Dr. Williams has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuralis.
Russell L. Chin, MD No disclosure on file
Jason H. Margolesky, MD, FAAN Dr. Margolesky has nothing to disclose.
Abraham Chileuitt, MD Dr. Chileuitt has nothing to disclose.
Erika T. Marulanda, MD, FAAN Dr. Marulanda has nothing to disclose.
Teshamae Monteith, MD, FAAN Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a 好色先生 with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a 好色先生 with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to AAN interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to AAN interests or activities.
Bridget T. Carey, MD No disclosure on file
Mandi Ellgen, MD Dr. Ellgen has nothing to disclose.
Jennifer J. Majersik, MD, FAAN Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Lee S. Chung, MD Dr. Chung has nothing to disclose.
Stephanie Lyden, MD Dr. Lyden has nothing to disclose.
Yao He No disclosure on file
Thomas M. Buchanan, MD Dr. Buchanan has nothing to disclose.
Kristena Hunsaker No disclosure on file
Jennifer A. Langsdorf, MD Dr. Langsdorf has nothing to disclose.
Tara Torabi, MD Dr. Torabi has nothing to disclose.
Ria Pal, MD Dr. Pal has nothing to disclose.
Trevor R. Rafferty, MD Dr. Rafferty has nothing to disclose.
Martavius T. Lovall, MD An immediate family member of Dr. Lovall has received personal compensation for serving as an employee of Sylllable .
Shefali Dujari, MD Dr. Dujari has nothing to disclose.
Lucia Rivera Lara, MD Dr. Rivera Lara has received personal compensation in the range of $5,000-$9,999 for serving as a expert witness with Legal firms.
Nirali Vora, MD Dr. Vora has nothing to disclose.
David Hartmann, MD, PhD Dr. Hartmann has nothing to disclose.
Mark Gudesblatt, MD The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Danielle A. Becker, MD Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Randa G. Jarrar, MD Dr. Jarrar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralis.
John M. Stern, MD, FAAN Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Adrian L. Rabinowicz, MD, FAAN Dr. Rabinowicz has received personal compensation for serving as an employee of Neurelis, Inc. Dr. Rabinowicz has stock in Neurelis, Inc.
Enrique Carrazana Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Pavel Klein, MD, FAAN The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Gewalin Aungaroon, MD Dr. Aungaroon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocodex. The institution of Dr. Aungaroon has received research support from Biocodex. The institution of Dr. Aungaroon has received research support from UCB. The institution of Dr. Aungaroon has received research support from Eysz. The institution of Dr. Aungaroon has received research support from Epygenix.
Victor Biton, MD Dr. Biton has nothing to disclose.
Kore K. Liow, MD, FACP The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Steven A. Phillips, MD No disclosure on file
Thomas Wychowski, MD The institution of Dr. Wychowski has received research support from UCB.
Ahmed H. Sadek, MD, FAAN Dr. Sadek has nothing to disclose.
Jan-Peer Elshoff, PhD Dr. Elshoff has nothing to disclose.
Robert Roebling No disclosure on file
Aliceson King Aliceson King has received personal compensation for serving as an employee of UCB Pharma. Aliceson King has stock in UCB.
Andrea Ford No disclosure on file
Chiara Rospo No disclosure on file
Rik Schoemaker No disclosure on file
Hugues Chanteux Hugues Chanteux has received personal compensation for serving as an employee of UCB. Hugues Chanteux has stock in UCB.
Barbara Bumstead, NP Ms. Bumstead has nothing to disclose.
Jesus E. Pina-Garza, MD Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Pina-Garza has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk. Dr. Pina-Garza has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Pina-Garza has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Analysis Group/Acadia. Dr. Pina-Garza has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Same as consultant disclosure. Dr. Pina-Garza has received publishing royalties from a publication relating to health care.
Michael Chez, MD, FAAN Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
James Cloyd No disclosure on file
Lawrence J. Hirsch, MD, FAAN Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Reetta Kälviäinen Reetta Kälviäinen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Reetta Kälviäinen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCBPharma. Reetta Kälviäinen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Angelini Pharma. The institution of Reetta Kälviäinen has received research support from Saastamoinen Foundation. The institution of Reetta Kälviäinen has received research support from Academy of Finland. The institution of Reetta Kälviäinen has received research support from Goverment of Finland. The institution of Reetta Kälviäinen has received research support from Jane and Aatos Erkko Foundation.
Lieven G. Lagae, PhD Dr. Lagae has nothing to disclose.
Raman Sankar, MD, PhD, FAAN Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sankar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for LivaNova. Dr. Sankar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sankar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BioMarin. Dr. Sankar has received publishing royalties from a publication relating to health care. Dr. Sankar has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NINDS, NIH.
Nicola Specchio Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Nicola Specchio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for stoke.
Adam Strzelczyk Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bicodex. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Desitin. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Adam Strzelczyk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Adam Strzelczyk has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UNEEG.
Manuel Toledo Manuel Toledo has nothing to disclose.
Eugen Trinka Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Marijean Buhse Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Jason Liu, MD Mr. Liu has nothing to disclose.
Manik Tetarbe, MD Dr. Tetarbe has nothing to disclose.
Tabassum Chowdhury, MD Ms. Chowdhury has nothing to disclose.
Melissa Ly, MD Miss Ly has nothing to disclose.
Shatha Wahbi Ms. Wahbi has nothing to disclose.
Maysaa M. Basha, MD, FAAN Dr. Basha has nothing to disclose.
Deepti Zutshi, MD, FAAN Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Arichena Ramanathan Manmatharayan, MD Dr. Ramanathan Manmatharayan has nothing to disclose.
Paul B. Lee, MD Dr. Lee has nothing to disclose.
Rene Andrade Machado, MD Prof. Andrade Machado has nothing to disclose.
Abdalhamid Lagnf, MD Dr. Lagnf has nothing to disclose.
Hassan Souidan, MD Dr. Souidan has nothing to disclose.
Taha Ataya, MD Dr. Ataya has nothing to disclose.
Farah Abdelhak Farah Abdelhak has nothing to disclose.
Rohan Thomas, MD Mr. Thomas has nothing to disclose.
Rami Fakhouri No disclosure on file
Younes Motii Younes Motii has nothing to disclose.
Margerie Durban, MD Dr. Durban has nothing to disclose.
Janaki Patel, MD Dr. Patel has nothing to disclose.
Dennis Parker Jr. No disclosure on file
Wazim Mohamed, MD Dr. Mohamed has nothing to disclose.
Mona Elsayed, MD Dr. Elsayed has nothing to disclose.
Cristina Jageka, MD Miss Jageka has nothing to disclose.
Gary Slatko, MD Dr. Slatko has received personal compensation for serving as an employee of Aquestive Therapeutics. Dr. Slatko has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aquestive Therapeutics.
Stephen Wargacki No disclosure on file
Michael A. Rogawski, MD, PhD Dr. Rogawski has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Xenon Pharmaceuticals.
Jennifer T. Kalina, MS No disclosure on file
Yoshinobu Hayakawa No disclosure on file
Ana Bartmann No disclosure on file
Cynthia L. Sullivan, PhD No disclosure on file
Michael D. Kolesnik, DO Dr. Kolesnik has nothing to disclose.
Tammie Tam, MD Dr. Tam has nothing to disclose.
Lori Ohanesian No disclosure on file
Jenny Wahl No disclosure on file
Lauren McKeon No disclosure on file
Margaret Gorlin No disclosure on file
Jeffrey A. Wilken, PhD No disclosure on file
Craig LaForce No disclosure on file
Laura Barlow No disclosure on file
Maria Burian No disclosure on file
S David Miller No disclosure on file
Glen M. Doniger, PhD No disclosure on file
William Cang No disclosure on file
Navaz Karanjia, MD Dr. Karanjia has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kenneth Sigelman, LLC. Dr. Karanjia has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris & Keplinger, LLC.
Jasmine Singh, MD Dr. Singh has nothing to disclose.
Geetika Bajpai, MBBS Dr. Bajpai has nothing to disclose.
Aashit K. Shah, MD, FAAN Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Chinekwu Anyanwu, MD, FAAN Dr. Anyanwu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Liva Nova.
Mark Witcher No disclosure on file
Joseph Hentz No disclosure on file
Lawrence H. Cohen Mr. Cohen has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mr. Cohen has stock in Takeda.
Thomas Ballard No disclosure on file
Yuu Moriya No disclosure on file
Mitsuhiro Nishihara No disclosure on file
Bei-Ching Chuang No disclosure on file
Miyuki Ugajin No disclosure on file
Hideki Hirabayashi No disclosure on file
Junzo Takahashi No disclosure on file
Yoshihiko Tagawa No disclosure on file
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Naga V. Pathi Jagannatham, MD Dr. Pathi Jagannatham has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Pathi Jagannatham has received personal compensation for serving as an employee of GlaxoSmithKline. Dr. Pathi Jagannatham has stock in Takeda Pharmaceuticals. Dr. Pathi Jagannatham has stock in GlaxoSmithKline.
Mahnaz Asgharnejad, PharmD Mahnaz Asgharnejad, PharmD has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Mahnaz Asgharnejad, PharmD has stock in GlaxoSmithKline. Mahnaz Asgharnejad, PharmD has stock in Takeda Pharmaceuticals.
Arturo I. Benitez, MD Dr. Benitez has received personal compensation for serving as an employee of Takeda.
Kosuke Nakashima No disclosure on file
Shinichi Kondo No disclosure on file
Christine Belden Christine Belden has nothing to disclose.
Stephane Baudouin, PhD Dr. Baudouin has received personal compensation for serving as an employee of Uniqure. Dr. Baudouin has stock in Uniqure.
Christophe Mulle No disclosure on file
Richard Porter No disclosure on file
Valerie Crepel No disclosure on file
Alfonso Represa No disclosure on file
Alaa Abdelsamad, MBBS Dr. Abdelsamad has nothing to disclose.
Nafisa Mustafa No disclosure on file
Osama Abdelsamad No disclosure on file
Renda Mahgoub No disclosure on file
Nadir Abdelrahman No disclosure on file
Caleb Marcin No disclosure on file
Pamela Engelhart No disclosure on file
Jason Lerner, MD Dr. Lerner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Lerner has or had stock in Biohaven Pharmaceuticals.
David Dill No disclosure on file
Gilbert J. L'Italien Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Vladimir Coric Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Joyce H. Matsumoto, MD Dr. Matsumoto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehman Group.
Michele Potashman, PhD Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
Leigh E. Charvet, PhD Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Omolara D. Kolawole, MD Dr. Kolawole has nothing to disclose.
Sri Raghav S. Sista, MD Dr. Sista has nothing to disclose.
Nabin Simkhada No disclosure on file
Prakash Adhikari No disclosure on file
Bishnu Pathak No disclosure on file
Bishal Dhakal Bishal Dhakal has nothing to disclose.
Krish Mahat No disclosure on file
Connor Bluntson, MD Mr. Bluntson has nothing to disclose.
Jordan C. Armstrong, MD Dr. Armstrong has nothing to disclose.
Mary A. Willis, MD, FAAN Dr. Willis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb.
Kaylan Burnham No disclosure on file
Matthew Kraus Mr. Kraus has nothing to disclose.
Joseph Nguyen, DO Dr. Nguyen has nothing to disclose.
Soo Hwan Park, MD Mr. Park has nothing to disclose.
Nishel Y. Kothari, MBBS Dr. Kothari has nothing to disclose.
Molly Perkins, MD Dr. Perkins has nothing to disclose.
Alexander P. Auchus, MD, FAAN Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms.
Abdelrahman E. Elfaham, MBBS Dr. Elfaham has nothing to disclose.
Ammar A. Jumah, MD Dr. Jumah has nothing to disclose.
Sat Dev Batish, PhD, FAAN Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Kyle Kaneko, DO Dr. Kaneko has nothing to disclose.
Erik L. Ortega, MD Dr. Ortega has received publishing royalties from a publication relating to health care.
Joseph J. Higgins, MD, FAAN No disclosure on file
Dhanya Gorty, MBBS Dr. Gorty has nothing to disclose.
Srikar Uppaluri No disclosure on file
Aleksei Rakitin, MD No disclosure on file
Hassnain A. Rizvi, DO Dr. Rizvi has nothing to disclose.
Amanda R. Sellers, MD Dr. Sellers has nothing to disclose.
Jeffrey Valencia Uribe No disclosure on file
Jorge E. Patino Murillas, MD Dr. Patino Murillas has nothing to disclose.
Hashim Talib Hashim Manea No disclosure on file
Saleh Abdulkareem Saleh No disclosure on file
Muntadher Almufadhal No disclosure on file
Zahraa Ali No disclosure on file
Mohammedbaqer Al-Ghuraibawi No disclosure on file
Manmeet P. Kaur, MD Dr. Kaur has nothing to disclose.
Nithisha Thatikonda, MBBS Dr. Thatikonda has nothing to disclose.
Jorge Rodriguez-Fernandez, MD Dr. Rodriguez-Fernandez has nothing to disclose.
Muhammad Z. Memon, MD Dr. Memon has nothing to disclose.
Sulev Haldre, PhD No disclosure on file
Christian Sidebottom, MD Mr. Sidebottom has nothing to disclose.
Walker Webster No disclosure on file
Anna Allen No disclosure on file
Danny Samkutty, MD Dr. Samkutty has nothing to disclose.
Anam Farrukh No disclosure on file
Shrikant Mishra, MD Dr. Mishra has nothing to disclose.
David B. Kudrow, MD Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Kudrow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie.
Linda Mosher No disclosure on file
Esther Straghan Esther Straghan has nothing to disclose.
Samantha Sweeney, Other Dr. Sweeney has received personal compensation for serving as an employee of Pfizer. Dr. Sweeney has stock in Pfizer.
Robert Fountaine Robert Fountaine has received personal compensation for serving as an employee of Pfizer, Inc.. Robert Fountaine has or had stock in Pfizer, Inc.Robert Fountaine has or had stock in Viatris, Inc.
Bhavesh Trikamji, MD Dr. Trikamji has nothing to disclose.
Ho Hyun Lee Mr. Lee has nothing to disclose.
Reyn Yoshioka Reyn Yoshioka has nothing to disclose.
Man Ian Woo Man Ian Woo has nothing to disclose.
Lana Liquard Lana Liquard has nothing to disclose.
Julia Jahansooz Julia Jahansooz has nothing to disclose.
Edward Weldon Edward Weldon has nothing to disclose.
Anson Lee Anson Lee has nothing to disclose.
Kyle Ishikawa Kyle Ishikawa has nothing to disclose.
Lydia Nicole Little, PhD, PA Dr. Little has nothing to disclose.
Jason Viereck, MD, PhD Dr. Viereck has nothing to disclose.
Maurice Vincent, MD, PhD Prof. Vincent has received personal compensation for serving as an employee of Eli Lilly and Company. Prof. Vincent has stock in Eli Lilly and Company.
Margaret Hoyt, PhD Dr. Hoyt has received personal compensation for serving as an employee of Eli Lilly and Co.. Dr. Hoyt has stock in Eli Lilly and Co..
Lucinda Hetherington No disclosure on file
Dustin Ruff Dustin Ruff has received personal compensation for serving as an employee of Eli Lilly and Company. Dustin Ruff has stock in Eli Lilly and Company.
Gilwan Kim No disclosure on file
Lars Viktrup No disclosure on file
William Lenderking No disclosure on file
Cynthia L. Comella, MD, FAAN Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Sakina Matcheswalla, MBBS Dr. Matcheswalla has nothing to disclose.
Kuldeep Yadav No disclosure on file
Rahul Jena, MBBS Mr. Jena has nothing to disclose.
Lakshmi Sai Deepak Reddy Velugoti, MD No disclosure on file
Aleksei Budnik No disclosure on file
Zabeen K. Mahuwala, MD, FAAN Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Scientific affairs. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Joel S. Perlmutter, MD, FAAN Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CHDI. Dr. Perlmutter has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Study Group. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Cooper and Peterson, LLC . Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Simmons and Simmons LLP . The institution of Dr. Perlmutter has received research support from NIH. The institution of Dr. Perlmutter has received research support from American Parkinson Disease Association (Advanced Research Center at Washington University). The institution of Dr. Perlmutter has received research support from CHDI. The institution of Dr. Perlmutter has received research support from Huntington Disease Society of America. The institution of Dr. Perlmutter has received research support from University of Western Toronto. The institution of Dr. Perlmutter has received research support from Barnes-Jewish Hospital Foundation. The institution of Dr. Perlmutter has received research support from Michael J Fox Foundation. The institution of Dr. Perlmutter has received research support from UCSD. The institution of Dr. Perlmutter has received research support from Paula & Rodger Riney FUnd. The institution of Dr. Perlmutter has received research support from Jo Oertli Fund. The institution of Dr. Perlmutter has received research support from Murphy FUnd. The institution of Dr. Perlmutter has received research support from Fixel Fund. The institution of Dr. Perlmutter has received research support from N Grant WIlliams Fund. The institution of Dr. Perlmutter has received research support from Pohlman Fund. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Boston University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a external advisor with Stanford University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with Beth Israel Hospital. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with U Pennsylvania.
Mariya Petrova Mariya Petrova has received personal compensation for serving as an employee of Click Therapeutics. Mariya Petrova has received research support from NIH.
Olya Besedina Miss Besedina has nothing to disclose.
Alankar Gupta, MD Dr. Gupta has nothing to disclose.
Brendan Hare No disclosure on file
Shaheen E. Lakhan, MD, PhD, MEd, FAAN Dr. Lakhan has received personal compensation for serving as an employee of Zogenix, Fern Health, Thriveworks, The Learning Corp, TriNet, Click Therapeutics. Dr. Lakhan has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Shaheen Lakhan, MD, PhD, LLC. Dr. Lakhan has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, Fern Health, Lin Health. Dr. Lakhan has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Click Therapeutics, SpineThera. Dr. Lakhan has stock in Zogenix, NeuroSport, Click Therapeutics, SpineThera.
H. A. Jinnah, MD, PhD, FAAN Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Alice Ke No disclosure on file
Ernesto Callegari No disclosure on file
Rajinder Bhardwaj The institution of Rajinder Bhardwaj has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Biohaven .
Manthena Varma No disclosure on file
Chieko Muto No disclosure on file
Richard Bertz Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.
Vaishali Sahasrabudhe No disclosure on file
Jing Liu Jing Liu has received personal compensation for serving as an employee of Pfizer, Inc.. Jing Liu has stock in Pfizer, Inc. .
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Pramoda Jayasinghe No disclosure on file
Fiona O'Sullivan No disclosure on file
Evan Popoff No disclosure on file
Lauren Powell Lauren Powell has nothing to disclose.
Jessica Cirillo No disclosure on file
Jessica Ailani, MD, FAAN Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Ailani has received personal compensation in the range of $0-$499 for serving as a Consultant for Eli Lilly. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ailani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aspya. Dr. Ailani has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kallyope. Dr. Ailani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Self Magazine. The institution of Dr. Ailani has received research support from Ipsen. The institution of Dr. Ailani has received research support from Parema. The institution of Dr. Ailani has received research support from Lundbeck. The institution of Dr. Ailani has received research support from Merz. The institution of Dr. Ailani has received research support from Pfizer. Dr. Ailani has received research support from Mi-Helper. The institution of Dr. Ailani has received research support from ShiraTronic. Dr. Ailani has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Lucy Abraham Lucy Abraham has received personal compensation for serving as an employee of Pfizer R&D UK Ltd. Lucy Abraham has stock in Pfizer R&D UK Ltd.
Richard L. Barbano, MD, PhD, FAAN Dr. Barbano has received personal compensation for serving as an employee of State of New York/Office of Mental Health. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. Dr. Barbano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Barbano has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Barbano has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Visual Dx. Dr. Barbano has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for R L Barbano, MD,PhD, PLLC. The institution of Dr. Barbano has received research support from Fox Foundation. The institution of Dr. Barbano has received research support from Dystonia Study Coalition. The institution of Dr. Barbano has received research support from Revance. Dr. Barbano has received intellectual property interests from a discovery or technology relating to health care.
Antranig G. Andonian Mr. Andonian has nothing to disclose.
Raghav Govindarajan, MD, FAAN Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Stewart A. Factor, DO, FAAN Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Ricky Paramo Mr. Paramo has nothing to disclose.
Lakshmi Leishangthem, MD, MBBS Dr. Leishangthem has nothing to disclose.
Christopher Edwards Christopher Edwards has nothing to disclose.
Susan Fox, MD, FAAN The institution of Dr. Fox has received research support from MJFF/Safra. The institution of Dr. Fox has received research support from Parkinson Canada. The institution of Dr. Fox has received research support from NIH. Dr. Fox has received publishing royalties from a publication relating to health care.
Scott M. Friedenberg, MD, FAAN The institution of Dr. Friedenberg has received research support from AMA. The institution of Dr. Friedenberg has received research support from Geisinger Medical Center.
Apoorva M. Pradhan, BAMS, MPH Dr. Pradhan has nothing to disclose.
Rachel M. Dragano, NP The institution of Ms. Dragano has received research support from Geisinger Health Plan.
Peyton Latorre No disclosure on file
Mallory Sponenberg No disclosure on file
Adriene Zook, PharmD Dr. Zook has nothing to disclose.
Henry Aftewicz No disclosure on file
Sandra Herr No disclosure on file
Michael Stoppie No disclosure on file
Jamie Kerestes No disclosure on file
Kim Mackes No disclosure on file
Jimmie Hill No disclosure on file
Raquel Martinez No disclosure on file
Jaime Silvagne No disclosure on file
Leeann Webster No disclosure on file
Alyssa M. Callela, PA Miss Callela has nothing to disclose.
Justin Kosman Mr. Kosman has nothing to disclose.
Eric Wright No disclosure on file
Leonard Learn No disclosure on file
Ronald J. Ellis, MD, PhD, FAAN Dr. Ellis has nothing to disclose.
Robert K Heaton The institution of Robert K Heaton has received research support from NIH. Robert K Heaton has received intellectual property interests from a discovery or technology relating to health care. Robert K Heaton has received intellectual property interests from a discovery or technology relating to health care.
J. Hampton Atkinson No disclosure on file
Murray Stein No disclosure on file
David Grelotti David Grelotti has nothing to disclose.
Jennifer Iudicello No disclosure on file
Scott L. Letendre, MD The institution of Dr. Letendre has received research support from National Institutes of Health. The institution of Dr. Letendre has received research support from University at Buffalo. Dr. Letendre has received publishing royalties from a publication relating to health care.
David Moore No disclosure on file
Karlos A. Acurio, MD Mr. Acurio has nothing to disclose.
Niels V. Pacheco, MD Mr. Pacheco has nothing to disclose.
Fernando J. Canazas-Paredes Mr. Canazas-Paredes has nothing to disclose.
Irving G. Calisaya-Madariaga, Sr. Mr. Calisaya-Madariaga has nothing to disclose.
Fritz F. Vascones Roman, Sr. Mr. Vascones Roman has nothing to disclose.
Diego F. Zambrano Mr. Zambrano has nothing to disclose.
Gabriela Garrido-Pinzas No disclosure on file
Kevin Pacheco-Barrios, MD Dr. Pacheco-Barrios has nothing to disclose.
Ajay Menon, MD Dr. Menon has nothing to disclose.
Cleo Zarina A. Reyes, MD Dr. Reyes has nothing to disclose.
Jay D. Varrato, DO Dr. Varrato has nothing to disclose.
Zaka U. Ahmed, MD, MBBS Dr. Ahmed has nothing to disclose.
Roger L. Weir, MD, FAAN Dr. Weir has nothing to disclose.
Talha Nazir, MD, MBBS No disclosure on file
Safia Mohamud, MD Dr. Mohamud has nothing to disclose.
Mosunmola Oyawusi, MD Dr. Oyawusi has nothing to disclose.
Carlos L. Vindel, MD Dr. Vindel has nothing to disclose.
Carla Valencia No disclosure on file
Mauricio Perez Davila, MD Dr. Perez Davila has nothing to disclose.
Anne-Gaelle Benoit No disclosure on file
Daniel C. Abenroth, MD Dr. Abenroth has nothing to disclose.
Raymond W. Grams II, DO Dr. Grams has nothing to disclose.
Raja Godasi, MBBS Dr. Godasi has nothing to disclose.
Yee K. Cheng, MD Dr. Cheng has nothing to disclose.
Neeharika Thottempudi, MD Dr. Thottempudi has nothing to disclose.
Sai Varun Bethina, MBBS Dr. Bethina has nothing to disclose.
Jacob Jeffrey Esper, DO Dr. Esper has nothing to disclose.
Rae E. Bacharach, DO Dr. Bacharach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生.
Jikku Jose Zachariah, DO Dr. Zachariah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS, Sanofi.
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Aaron Creswell, MS Mr. Creswell has nothing to disclose.
Cortney Connor Miss Connor has nothing to disclose.
For-Shing Lui, MD, FAAN Dr. Lui has nothing to disclose.
Shahnawaz Karim, MBBS Dr. Karim has received personal compensation for serving as an employee of TPMG.
Sally Tu Miss Tu has nothing to disclose.
Raymond K. Ko Mr. Ko has nothing to disclose.
Olivier Outteryck Olivier Outteryck has nothing to disclose.
Mohamed S. Shehata, MBBS Dr. Shehata has nothing to disclose.
Amany Mahfouz No disclosure on file
Hossam T. Ali, MD Dr. Ali has nothing to disclose.
Aya Al Mawla No disclosure on file
Mostafa M. Meshref, MD Dr. Meshref has nothing to disclose.
Abdelmonem Siddiq No disclosure on file
Roopa Sharma, MD Dr. Sharma has nothing to disclose.
Kazim Jaffry Mr. Jaffry has nothing to disclose.
Justin Matos No disclosure on file
Scott Karpenos No disclosure on file
James Lin, MS Mr. Lin has nothing to disclose.
Narjis Jaffry No disclosure on file
Kranthi K. Mandava Mr. Mandava has nothing to disclose.
Daniel L. Menkes, MD, FAAN An immediate family member of Dr. Menkes has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Menkes has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CMTE. An immediate family member of Dr. Menkes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Menkes has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Self Employed. An immediate family member of Dr. Menkes has received research support from Helmsley Foundation . An immediate family member of Dr. Menkes has received intellectual property interests from a discovery or technology relating to health care.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Suhayb Islam Mr. Islam has nothing to disclose.
Harini Sarva, MD, FAAN Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuroderm. Dr. Sarva has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Insightec. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Sun Pharma. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB. The institution of Dr. Sarva has received research support from MeiraGTX. The institution of Dr. Sarva has received research support from Biohaven. The institution of Dr. Sarva has received research support from Vima.
Claire Henchcliffe, MD, PhD, FAAN Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Savanna. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has or had stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Parkinson Study Group. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Course director with AAN. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic Foundation. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vertex. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ESGCT.
Andres M. Lozano, MD Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Suneil Kalia Suneil Kalia has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Suneil Kalia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novonordisk. The institution of Suneil Kalia has received research support from CIHR. Suneil Kalia has received research support from MJFF. The institution of Suneil Kalia has received research support from Parkinson Canada.
Kenny Yu Kenny Yu has nothing to disclose.
Cameron Brennan Cameron Brennan has nothing to disclose.
Michele K. York, PhD, ABPP-CN Dr. York has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RAD-PD. The institution of Dr. York has received research support from Michael J. Fox Foundation. The institution of Dr. York has received research support from NIH. The institution of Dr. York has received research support from Takeda.
Whitney Stemple Whitney Stemple has received personal compensation for serving as an employee of BlueRock Therapeutics.
Nauman Abid, MD Dr. Abid has received personal compensation for serving as an employee of BlueRock Therapeutics.
Marcus Yountz, MD, FAAN Dr. Yountz has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease. Dr. Yountz has stock in AstraZeneca.
Ahmed Enayetallah, PhD, MBBCh Dr. Enayetallah has received personal compensation for serving as an employee of Alexion. Dr. Enayetallah has received stock or an ownership interest from Alexion. Dr. Enayetallah has received stock or an ownership interest from AstraZeneca.
Antoine Lampron, PhD Mr. Lampron has received personal compensation for serving as an employee of Bluerock Therapeutics. Mr. Lampron has received personal compensation for serving as an employee of Alexion Inc..
Viviane Tabar Viviane Tabar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. An immediate family member of Viviane Tabar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BlueRock. The institution of Viviane Tabar has received research support from BlueRock. The institution of an immediate family member of Viviane Tabar has received research support from BlueRock. Viviane Tabar has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Viviane Tabar has received intellectual property interests from a discovery or technology relating to health care.
Todd Grinnell, PhD Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Aleksandra Podlewska, PhD Miss Podlewska has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bial . The institution of Miss Podlewska has received research support from Wellcome Trust.
Lucia Batzu No disclosure on file
Juliet Staunton No disclosure on file
Phoebe Tall No disclosure on file
Valentina Leta No disclosure on file
Alexandra Rizos No disclosure on file
Fleur Fleur No disclosure on file
Alison Hartley No disclosure on file
Tayana Soukup No disclosure on file
Nick Sevdalis No disclosure on file
Andrew Healey No disclosure on file
Ioannis Bakolis No disclosure on file
Carmine Pariante No disclosure on file
Anthony Woods No disclosure on file
Kallol R. Chaudhuri, MD, FRCP Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Nikki Crane No disclosure on file
Helen E. Stephens No disclosure on file
Rajesh Pahwa, MD, FAAN Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Thomas E. Kimber, PhD, FRACP Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Seqiris. Dr. Kimber has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Kimber has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer.
Okeanis Vaou, MD, FAAN Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ABBVIE. Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Vaou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Vaou has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for medtronic. An immediate family member of Dr. Vaou has stock in SAGE. The institution of Dr. Vaou has received research support from Medtronic.
Lars Bergmann, MD Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.
Jason L. Aldred, MD, FAAN Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Aldred has received personal compensation in the range of $0-$499 for serving as a Consultant for Quadralynx. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Aldred has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Aldred has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for TEVA. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US World Meds. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Aldred has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Aldred has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Aldred has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Arete Neuroscience, PLLC. The institution of Dr. Aldred has received research support from Biogen . The institution of Dr. Aldred has received research support from Abbvie. The institution of Dr. Aldred has received research support from Merz. The institution of Dr. Aldred has received research support from AstraZeneca. The institution of Dr. Aldred has received research support from Neurocrine. The institution of Dr. Aldred has received research support from Aptinyx. The institution of Dr. Aldred has received research support from Cerevance. The institution of Dr. Aldred has received research support from Boston Scientific . The institution of Dr. Aldred has received research support from Parkinson Foundation . The institution of Dr. Aldred has received research support from Roche. The institution of Dr. Aldred has received research support from Sage Therapeutics. The institution of Dr. Aldred has received research support from Annovis. The institution of Dr. Aldred has received research support from Biovie. The institution of Dr. Aldred has received research support from NeuroDerm. The institution of Dr. Aldred has received research support from PhotoPharma. The institution of Dr. Aldred has received research support from Lilly.
Leonard Verhagen Metman, MD, PhD Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Jaclyn C. Homola, PharmD Dr. Homola has received personal compensation for serving as an employee of AbbVie. Dr. Homola has stock in AbbVie.
Jia Jia, PhD Mr. Jia has received personal compensation for serving as an employee of Abbvie.
Megha Shah Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
William Ondo, MD Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Stanley Fisher, MD, FAAN Dr. Fisher has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Ghazal Banisadr, PhD Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Richard D'Souza Richard DSouza has received personal compensation for serving as an employee of Amneal Pharmaceuticals. Richard DSouza has stock in Amneal Pharmaceuticals .
Bruno Bergmans Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie Inc.. Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz GmbH. Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Bruno Bergmans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie Inc.. The institution of Bruno Bergmans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz GmbH. The institution of Bruno Bergmans has received research support from Abbvie Inc.. The institution of Bruno Bergmans has received research support from Merz GmbH. Bruno Bergmans has a non-compensated relationship as a MDS Young Members Group Steering Committee Vice-Chair with International Parkinson and Movement DIsorder Society (MDS) that is relevant to AAN interests or activities.
Irene Malaty, MD, FAAN Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Daniel L. Cobb, MD Dr. Cobb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Cobb has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Cobb has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cook Law Group. The institution of Dr. Cobb has received research support from Harmony. The institution of Dr. Cobb has received research support from Abbvie.
Resmi Gupta Resmi Gupta has nothing to disclose.
Zachary Simmons, MD, FAAN Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Michael Soileau, MD, FAAN The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Soileau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Soileau has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Abbvie. Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Soileau has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz. The institution of Dr. Soileau has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Soileau has received research support from Abbvie. The institution of Dr. Soileau has received research support from Cerevel. The institution of Dr. Soileau has received research support from Praxis. The institution of Dr. Soileau has received research support from CND Life Sciences. The institution of Dr. Soileau has received research support from Teva. The institution of Dr. Soileau has received research support from Abbott. The institution of Dr. Soileau has received research support from Jazz Pharmaceuticals. The institution of Dr. Soileau has received research support from Scion. Dr. Soileau has received publishing royalties from a publication relating to health care. Dr. Soileau has a non-compensated relationship as a Past President with Texas Neurological Society that is relevant to AAN interests or activities.
Zach Baldwin No disclosure on file
Connie H. Yan, PhD, PharmD Dr. Yan has received personal compensation for serving as an employee of AbbVie Inc. Dr. Yan has stock in AbbVie Inc.
Triza Brion No disclosure on file
Alex Bellenger No disclosure on file
JeeHee Suh No disclosure on file
Pavnit Kukreja, PharmD Dr. Kukreja has received personal compensation for serving as an employee of AbbVie. Dr. Kukreja has stock in AbbVie.
Maurizio Facheris, MD, MSc Dr. Facheris has received personal compensation for serving as an employee of Vanqua Bio. Dr. Facheris has stock in Vanqua Bio.
Anand R. Shewale Anand R. Shewale has received personal compensation for serving as an employee of AbbVie. Anand R. Shewale has stock in AbbVie.
Rajeev Kumar, MD, FRCPC The institution of Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Teva Pharmaceuticals. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Annexon. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda Therapeutics. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevel Therapeutics. Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cerevance. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ferrer. Dr. Kumar has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Kumar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Research Catalyst, LLC. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for CenExel RMCR. Dr. Kumar has stock in Research Catalyst, LLC. Dr. Kumar has stock in CenExel. Dr. Kumar has stock in Neurofold Therapeutics. The institution of Dr. Kumar has received research support from Supernus. The institution of Dr. Kumar has received research support from Sage Therapeutics. The institution of Dr. Kumar has received research support from Prilenia Therapeutics. The institution of Dr. Kumar has received research support from Roche. The institution of Dr. Kumar has received research support from Triplet Therapeutics. The institution of Dr. Kumar has received research support from CHDI Foundation. The institution of Dr. Kumar has received research support from Neurocrine Biosciences. The institution of Dr. Kumar has received research support from Biovie. The institution of Dr. Kumar has received research support from Neuroderm. The institution of Dr. Kumar has received research support from Sanofi. The institution of Dr. Kumar has received research support from Addex Pharma. The institution of Dr. Kumar has received research support from Integrative Research Laboratories. The institution of Dr. Kumar has received research support from Takeda Pharmaceuticals. The institution of Dr. Kumar has received research support from Neuraly. The institution of Dr. Kumar has received research support from Abbvie. The institution of Dr. Kumar has received research support from Cerevel Therapeutics. The institution of Dr. Kumar has received research support from Transposon Therapeutics. The institution of Dr. Kumar has received research support from Lundbeck. The institution of Dr. Kumar has received research support from Biohaven. The institution of Dr. Kumar has received research support from Revance Therapeutics. The institution of Dr. Kumar has received research support from Impax Laboratories. The institution of Dr. Kumar has received research support from CND Life Sciences. The institution of Dr. Kumar has received research support from Neuron23. The institution of Dr. Kumar has received research support from Annexon Biosciences. The institution of Dr. Kumar has received research support from Annovis. The institution of Dr. Kumar has received research support from PTC Therapeutics. The institution of Dr. Kumar has received research support from Uniqure. The institution of Dr. Kumar has received research support from Alexza. The institution of Dr. Kumar has received research support from SparkNeuro. The institution of Dr. Kumar has received research support from Praxis. The institution of Dr. Kumar has received research support from Scion Neurostim. The institution of Dr. Kumar has received research support from Cognition Therapeutics. The institution of Dr. Kumar has received research support from Eli Lilly. The institution of Dr. Kumar has received research support from Aribio. The institution of Dr. Kumar has received research support from Biogen. The institution of Dr. Kumar has received research support from Bial R and D investments. The institution of Dr. Kumar has received research support from Ono Pharmaceutical Company. The institution of Dr. Kumar has received research support from UCB Biopharma. The institution of Dr. Kumar has received research support from Vigil Therapeutics. Dr. Kumar has received personal compensation in the range of $100,000-$499,999 for serving as a Medical Director with CenExel RMCR. Dr. Kumar has received personal compensation in the range of $1,000,000+ for serving as a Managing Member with Research Catalyst, LLC. Dr. Kumar has a non-compensated relationship as a Board Member with Movement Disorders Foundation that is relevant to AAN interests or activities.
Sankar P. Gorthi, MD, FAAN Dr. Gorthi has nothing to disclose.
Alfonso Fasano, MD, PhD, FAAN Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Fasano has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Fasano has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceregate. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Inbrain Neuroelectronics. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Annovis. Dr. Fasano has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CADTH. Dr. Fasano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society. The institution of Dr. Fasano has received research support from Boston Scientific. The institution of Dr. Fasano has received research support from Medtronic. The institution of Dr. Fasano has received research support from Abbvie. The institution of Dr. Fasano has received research support from Canadian Institutes of Health Research (CIHR). The institution of Dr. Fasano has received research support from Michael J Fox Foundation. The institution of Dr. Fasano has received research support from Bluerock Therapeutics. Dr. Fasano has received publishing royalties from a publication relating to health care. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with CenteR for Advancing Neurological Innovation to Application (CRANIA) that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with HopeNET that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Medical Advisory Committee with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Member with Tremor Research Group that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Co-Chair with Tremor Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with NPH Study Group of the IPMDS that is relevant to AAN interests or activities. Dr. Fasano has a non-compensated relationship as a Vice-Chair with Industry Committee of the IPMDS that is relevant to AAN interests or activities.
Victor Fung, MD, MBBS, PhD Dr. Fung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fung has received publishing royalties from a publication relating to health care.
Filip Bergquist The institution of Filip Bergquist has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Filip Bergquist has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Arvid Carlsson Research AB. The institution of Filip Bergquist has received research support from Swedish Government. The institution of Filip Bergquist has received research support from Parkinsonfonden. The institution of Filip Bergquist has received research support from Neuro Sweden. The institution of Filip Bergquist has received research support from Swedish Research Council. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has received publishing royalties from a publication relating to health care. Filip Bergquist has a non-compensated relationship as a Advisor with Sense4Care that is relevant to AAN interests or activities.
Sara S. Dhanani, MD Dr. Dhanani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Florin Gandor No disclosure on file
Stuart H. Isaacson, MD, FAAN The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Anna Jeong, MD Dr. Jeong has received personal compensation for serving as an employee of AbbVie. An immediate family member of Dr. Jeong has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Stryker. Dr. Jeong has stock in AbbVie.
Amy M. Spiegel, PhD Amy Spiegel has received personal compensation for serving as an employee of AbbVie. Amy Spiegel has received stock or an ownership interest from AbbVie.
Tara Skarpaas No disclosure on file
Guenther Deuschl, MD, FAAN Dr. Deuschl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Cavion Functional Neuromodulation. The institution of Dr. Deuschl has received research support from Medtronic. Dr. Deuschl has received publishing royalties from a publication relating to health care.
Michelle Baladi, PhD Dr. Baladi has stock in Jazz Pharmaceuticals .
Patricia Chandler Patricia Chandler has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Patricia Chandler has stock in Jazz Pharmaceuticals.
Kan Xu No disclosure on file
Peter A. LeWitt, MD Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.
Aaron Ellenbogen, DO Dr. Ellenbogen has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for allergan. Dr. Ellenbogen has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for allergan. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ipsen. Dr. Ellenbogen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda.
Nelson F. Lopes Dr. Lopes has received personal compensation for serving as an employee of Neuroderm.
Milton H. Werner No disclosure on file
Andrew J. McGarry, MD Dr. McGarry has received personal compensation for serving as an employee of Clintrex Research Corporation.
Christopher Meyer No disclosure on file
Emaryn Mancino No disclosure on file
Carl Klint No disclosure on file
Jacqueline Pellecchia No disclosure on file
C. W. Olanow, MD Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Fabrizio Stocchi Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Vanda Lennon, MD, PhD The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Peggy Auinger Ms. Auinger has nothing to disclose.
Esther Rodriguez-Forti Esther Rodriguez-Forti has nothing to disclose.
Chadwick W. Christine, MD, FAAN The institution of Dr. Christine has received research support from Michael J Fox Foundation for Parkinson's Research. The institution of Dr. Christine has received research support from Aspen Neurosciences. The institution of Dr. Christine has received research support from ASK BIo. The institution of Dr. Christine has received research support from Bayer.
Noemi Cannizzaro No disclosure on file
Ralph Green Dr. Green has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WiiTi. Dr. Green has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott.
David Oakes No disclosure on file
Lyvin Tat Lyvin Tat has nothing to disclose.
Hamidreza Ghodsi, MD Dr. Ghodsi has nothing to disclose.
Jong-Min Moon No disclosure on file
Chochanon Moonla Chochanon Moonla has nothing to disclose.
Kuldeep Mahato Kuldeep Mahato has nothing to disclose.
Irene Litvan, MD, FAAN Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aprinoia. Dr. Litvan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Litvan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology. Dr. Litvan has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Editor with Frontiers in Neurology.
Joseph Wang Joseph Wang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for VitalTrace.
Katherine Longardner, MD Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Longardner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Trisalus. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZenica. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sirtex. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Society of Interventional Oncology. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for France Foundation. An immediate family member of Dr. Longardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Varian. Dr. Longardner has received research support from NIH.
Hwai Y. Ooi, MD Dr. Ooi has nothing to disclose.
Kristina A. Zawaly, PhD Dr. Zawaly has nothing to disclose.
Mark Reed Mr. Reed has nothing to disclose.
Sarah Mulukutla, MD, MPH, FAAN Dr. Mulukutla has received personal compensation in the range of $5,000-$9,999 for serving as a Meditation instructor & speaker with Weill Cornell Medicine.
Alexandria Umbarger No disclosure on file
Sandra Kletzel The institution of Sandra Kletzel has received research support from Office of Research Development, VA.
Blake McReavy Mr. McReavy has nothing to disclose.
Sadie Walker No disclosure on file
Miloni Shah Miloni Shah has nothing to disclose.
Rama Alsakaji No disclosure on file
Kalea L. Colletta, DO Dr. Colletta has nothing to disclose.
Erika S. Horta, MD Dr. Horta has nothing to disclose.
Ryan Reyes Mr. Reyes has nothing to disclose.
Alia T. Sadek Ms. Sadek has nothing to disclose.
Leila Djerdjour Miss Djerdjour has nothing to disclose.
Greggory Adams No disclosure on file
Margaret Smith No disclosure on file
Cara Logan No disclosure on file
Sara Biddle No disclosure on file
Enrique Urrea-Mendoza, MD Dr. Urrea-Mendoza has nothing to disclose.
Tracie McConnell No disclosure on file
Fredy J. Revilla, MD, FAAN Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA .
Jennifer Trilk No disclosure on file
Nuttapat Tungtrongchitr No disclosure on file
Pisut Pongchaikul No disclosure on file
Wannisa Wongpipathpong, MD Miss Wongpipathpong has nothing to disclose.
Nantaporn Srivanitchapoom No disclosure on file
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Caroline M. Tanner, MD, PhD, FAAN Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Hans-Peter Hartung, MD, FAAN Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Peiqing Qian, MD Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Qian has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS.
Derrick Robertson, MD Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Greenwich Biosciences. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mallinckrodt. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Robertson has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for PRIME CME. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Robertson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McVeigh. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mccumber. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Goodis. The institution of Dr. Robertson has received research support from Biogen. The institution of Dr. Robertson has received research support from EMD Serono. The institution of Dr. Robertson has received research support from Jansenn. The institution of Dr. Robertson has received research support from Genentech. The institution of Dr. Robertson has received research support from Patient-Centered Outcomes Research Institute. The institution of Dr. Robertson has received research support from Novartis. The institution of Dr. Robertson has received research support from Sanofi Genzyme. The institution of Dr. Robertson has received research support from TG Therapeutics. The institution of Dr. Robertson has received research support from Prime. The institution of Dr. Robertson has received research support from Greenwich Biosciences. The institution of Dr. Robertson has received research support from Atara Biotherapeutics. The institution of Dr. Robertson has received research support from CorEvitas. The institution of Dr. Robertson has received research support from Anokion. The institution of Dr. Robertson has received research support from UCB Biosciences. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Consortium of Multiple Sclerosis Centers. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Lily Lee, PhD Dr. Lee has nothing to disclose.
Koby Mok, PhD Dr. Mok has received personal compensation for serving as an employee of TG Therapeutics. Dr. Mok has received stock or an ownership interest from TG Therapeutics.
Chris Garner Chris Garner has received personal compensation for serving as an employee of TG Therapeutics Inc.. Chris Garner has stock in TG Therapeutics, Inc..
Fernando F. Figueira, MD No disclosure on file
Anne H. Cross, MD, FAAN Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Stephen L. Hauser, MD Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NGM Bio. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pheno Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nurix Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Accure. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hinge Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Neurona. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Roche that is relevant to AAN interests or activities. Dr. Hauser has a non-compensated relationship as a Clinical Trial/Primary Investigator with Novartis that is relevant to AAN interests or activities.
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Patricia K. Coyle, MD, FAAN Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Accordant. Dr. Coyle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Coyle has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi Genzyme. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GlaxoSmithKline. Dr. Coyle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Coyle has received research support from CorEvitas LLC. The institution of Dr. Coyle has received research support from Genentech/Roche. The institution of Dr. Coyle has received research support from NINDS. The institution of Dr. Coyle has received research support from Sanofi Genzyme. The institution of Dr. Coyle has received research support from Cleveland Clinic.
Xavier Montalban, MD, PhD, FAAN The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Haoyi Fu Haoyi Fu has received personal compensation for serving as an employee of Novartis. Haoyi Fu has stock in Novartis.
Alit Bhatt Alit Bhatt has nothing to disclose.
Ibolya Boer, MD Ibolya Boer has received personal compensation for serving as an employee of Novartis AG.
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Gustavo Figueira, MD No disclosure on file
Yadi Li No disclosure on file
Amy Kunchok, MBBS Dr. Kunchok has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology:Open Access Journal .
Marisa P. McGinley, DO Dr. McGinley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. McGinley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. McGinley has received research support from Biogen. The institution of Dr. McGinley has received research support from Genentech. The institution of Dr. McGinley has received research support from NIH. The institution of Dr. McGinley has received research support from AHRQ. The institution of Dr. McGinley has received research support from EMD Serono.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Saira Afzal, MD Dr. Afzal has nothing to disclose.
Brittany Lapin No disclosure on file
Lucy Kennedy No disclosure on file
Gavin Brittain, MBBS Dr. Brittain has nothing to disclose.
Basil Sharrack, MD, PhD, FAAN Dr. Sharrack has nothing to disclose.
John Snowden John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. John Snowden has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS.
Cindy Cooper The institution of Cindy Cooper has received research support from NIHR.
Paolo Muraro Paolo Muraro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Pinsent Masons LLP. Paolo Muraro has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Taylor Wessing LLP. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bugge Valentin. Paolo Muraro has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lambert Hornby LLP. The institution of Paolo Muraro has received research support from NIHR-EME. The institution of Paolo Muraro has received research support from Benaroya Research Institute.
Elisa Roldan Galvan Elisa Roldan Galvan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Diana Papaioannou No disclosure on file
Rachel Glover Rachel Glover has nothing to disclose.
Amanda Loban No disclosure on file
Trygve Holmoy, MD Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Norwegian MS Society. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Holmoy has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Jens Wuerfel, MD Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Yanic Heer No disclosure on file
Stefan Braune Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Arnfin Bergmann Dr. Bergmann has nothing to disclose.
Mel Zürcher No disclosure on file
Sabrina Guye No disclosure on file
Thomas Kuenzel No disclosure on file
Suzanne Moore Suzanne Moore has received personal compensation for serving as an employee of Hoffmann-la-Roche. Suzanne Moore has stock in Hoffmann-la-Roche.
Timothy L. Vollmer, MD, FAAN The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Jason W. Freeman, MD Dr. Freeman has received personal compensation for serving as an employee of Novartis . Dr. Freeman has stock in Novartis .
Sylvia R. Delgado, MD, FAAN The institution of Dr. Delgado has received research support from Novartis. The institution of Dr. Delgado has received research support from EMD Serono.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Annette Okai, MD, FAAN Dr. Okai has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme . The institution of Dr. Okai has received research support from Sanofi Genzyme. The institution of Dr. Okai has received research support from Roche Genetech. The institution of Dr. Okai has received research support from Novartis. The institution of Dr. Okai has received research support from EMD Serono. The institution of Dr. Okai has received research support from TG Therapeutics.
Wenjia Wei Wenjia Wei has received personal compensation for serving as an employee of Novartis.
Tjalf Ziemssen, MD, FAAN Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Daniel J. Licht, MD No disclosure on file
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Tobias Derfuss An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Roche. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuraxpharm. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Sharp Dome. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has stock in Novartis. An immediate family member of Tobias Derfuss has stock in Roche. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen. The institution of Tobias Derfuss has received research support from Alexion.
Krzysztof W. Selmaj Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Kevin Winthrop Kevin Winthrop has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson & Johnson .
Paul S. Giacomini, MD Dr. Giacomini has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Innodem Neurosciences. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. Hoffmann- La Roche. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffmann-La Roche. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for F. Hoffman-La Roche. Dr. Giacomini has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Giacomini has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi.
Francesco Sacca, MD, FAAN Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lexeo. Dr. Sacca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genpharm. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medpharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Madison Pharma. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zai Lab. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reata. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neopharm Israel. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson&Johnson. Dr. Sacca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Sacca has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Astrazeneca. The institution of Dr. Sacca has received research support from AIFA. The institution of Dr. Sacca has received research support from FARA.
Xixi Hu Xixi Hu has received personal compensation for serving as an employee of Novartis. Xixi Hu has stock in Novartis.
Roseanne Sullivan Roseanne Sullivan has received personal compensation for serving as an employee of Novartis Pharmaceuticals. Roseanne Sullivan has stock in Novartis Pharmaceuticals.
Valentine Jehl Valentine Jehl has received personal compensation for serving as an employee of Novartis Pharma AG. Valentine Jehl has stock in Novartis. Pharma AG.
Gabriel Pardo, MD, FAAN Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen . Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Pardo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Pardo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Pardo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Pardo has or had stock in Progentec Diagnostics.Dr. Pardo has or had stock in Cadenza Bio.
Jing Xi No disclosure on file
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Natalia Khachanova Natalia Khachanova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Natalia Khachanova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Natalia Khachanova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Natalia Khachanova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. Natalia Khachanova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Aventis. Natalia Khachanova has received research support from Sanofi-Aventis. Natalia Khachanova has received research support from Roche. Natalia Khachanova has received research support from Merck. Natalia Khachanova has received research support from Novartis. Natalia Khachanova has received research support from Actelion Pharmaceuticals. Natalia Khachanova has received research support from TG Therapeutics.
Rebecca Piccolo, PhD Dr. Piccolo has received personal compensation for serving as an employee of Novartis. Dr. Piccolo has stock in Novartis.
Nasrin Rahimian, MD Dr. Rahimian has nothing to disclose.
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Afsaneh Shirani, MD, FAAN Dr. Shirani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics.
Jacqueline A. Nicholas, MD Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squib. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Nicholas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vielo Bio. Dr. Nicholas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Nicholas has received research support from Novartis. The institution of Dr. Nicholas has received research support from Biogen. The institution of Dr. Nicholas has received research support from Genentech. The institution of Dr. Nicholas has received research support from PCORI. Dr. Nicholas has a non-compensated relationship as a Physician with National MS Society that is relevant to AAN interests or activities. Dr. Nicholas has a non-compensated relationship as a Physician with Siegal Rare Neuroimmune Association that is relevant to AAN interests or activities.
Sven G. Meuth Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Brandi L. Vollmer, MPH Ms. Vollmer has nothing to disclose.
Timber Bourassa No disclosure on file
Erin Marsh No disclosure on file
Vi Dao No disclosure on file
Brandon Brown No disclosure on file
Abhijit Gadkari No disclosure on file
Stefan Sillau Stefan Sillau has nothing to disclose.
Kavita Nair, PhD, FAAN Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to AAN interests or activities.
Sonya U. Steele, MD No disclosure on file
Jiwon Oh, MD, FAAN Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Anastasiia Raievska No disclosure on file
Malgorzata Sierzega Malgorzata Sierzega has stock in Roche.
Joao J. Cerqueira, MD, PhD Dr. Cerqueira has received personal compensation for serving as an employee of João José Cerqueira Unipessoal Lda. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cerqueira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. The institution of Dr. Cerqueira has received research support from Biogen.
Claire Riley, MD, FAAN Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Maresa Caunt Mrs. Caunt has received personal compensation for serving as an employee of Genentech. Mrs. Caunt has stock in Genentech.
John Ratchford, MD Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Alexandra L. Goodyear, MD Dr. Goodyear has received personal compensation for serving as an employee of Genentech. Dr. Goodyear has received personal compensation for serving as an employee of Novartis. Dr. Goodyear has stock in Novartis. Dr. Goodyear has stock in Genentech.
Konstantina Vanevski No disclosure on file
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Robert H. Gross, MD, FAAN Dr. Gross has nothing to disclose.
Sean Selva Sean Selva has nothing to disclose.
Alanna Ritchie Alanna Ritchie has nothing to disclose.
Carrie M. Hersh, DO, MSc, FAAN Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Moein Amin, MD Dr. Amin has nothing to disclose.
Tucker Harvey No disclosure on file
Brandon P. Moss, MD An immediate family member of Dr. Moss has stock in Pfizer. The institution of Dr. Moss has received research support from Novartis. The institution of Dr. Moss has received research support from Genentech.
Ming-Hui Tai No disclosure on file
Devon Conway, MD Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Wakiro Sato Wakiro Sato has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Wakiro Sato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharma. Wakiro Sato has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma.
Tomoko Okamoto Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharma G.K.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical Co., Ltd.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teijin Pharma Limited.. The institution of Tomoko Okamoto has received research support from Alexion Pharma G.K.. The institution of Tomoko Okamoto has received research support from Sanofi. The institution of Tomoko Okamoto has received research support from Novartis. The institution of Tomoko Okamoto has received research support from UCB Japan Co., Ltd. The institution of Tomoko Okamoto has received research support from Biogen Japan Ltd.. The institution of Tomoko Okamoto has received research support from Chugai Pharmaceutical Co., Ltd.. The institution of Tomoko Okamoto has received research support from Mitsubishi Tanabe Pharma Corporation. Tomoko Okamoto has received intellectual property interests from a discovery or technology relating to health care.
Youwei Lin No disclosure on file
Yukio Kimura No disclosure on file
Noriko Sato No disclosure on file
Yuko Shimizu, MD, PhD Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen Japan.. Dr. Shimizu has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis Pharma. Dr. Shimizu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chigai Pharma CoLtd.
Yoichiro Nishida Yoichiro Nishida has nothing to disclose.
Takanori Yokota, MD, PhD Dr. Yokota has nothing to disclose.
Masanori Taketsuna No disclosure on file
Yu Okada No disclosure on file
Takami Ishizuka No disclosure on file
Harumasa Nakamura, MD Dr. Nakamura has nothing to disclose.
Sachiko Miyajke No disclosure on file
Yuji Takahashi, MD, PhD The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Takashi Yamamura, MD Dr. Yamamura has nothing to disclose.
Chelsie Thompson, DO Dr. Thompson has nothing to disclose.
Lakshman N. Arcot Jayagopal, MD Dr. Arcot Jayagopal has nothing to disclose.
Mac McLaughlin, MD Dr. McLaughlin has nothing to disclose.
Renee Stewart, RN, NP Mrs. Stewart has nothing to disclose.
Rana K. Zabad, MD, FAAN Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene/BMS. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck Serono. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Neurosciences. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Dr. Zabad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. The institution of Dr. Zabad has received research support from Adamas. The institution of Dr. Zabad has received research support from Biogen. The institution of Dr. Zabad has received research support from Novartis. The institution of Dr. Zabad has received research support from Sun Pharma. The institution of Dr. Zabad has received research support from Parexel & MedDay Pharmaceuticals.
Nicole Dafney No disclosure on file
Vanessa Ellenberger No disclosure on file
Angela French No disclosure on file
Melanie Lozano No disclosure on file
Rebecca Napoliello No disclosure on file
Anne Gocke, PhD No disclosure on file
Sara Bosticardo Miss Bosticardo has nothing to disclose.
Po-Jui Lu No disclosure on file
Ian Tagge No disclosure on file
Bing Zhu Bing Zhu has received personal compensation for serving as an employee of Biogen. Bing Zhu has received stock or an ownership interest from Biogen.
Cristina Granziera, MD, PhD The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen.
Alessandro Daducci No disclosure on file
Eunice J. Lee, MD Dr. Lee has nothing to disclose.
Madeline Russell, MD Dr. Russell has nothing to disclose.
Muhammad Athar Muhammad Athar has nothing to disclose.
Omar S. Shah, MD No disclosure on file
Ralph Habis, MD Dr. Habis has nothing to disclose.
Ashley Heck No disclosure on file
Paris Bean No disclosure on file
John Probasco, MD, FAAN Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech.
Romergryko G. Geocadin, MD, FAAN Dr. Geocadin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Consulting.
Rodrigo Hasbun Rodrigo Hasbun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biomeriaux. The institution of Rodrigo Hasbun has received research support from Biomeriaux.
Arun Venkatesan, MD, PhD Dr. Venkatesan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. The institution of Dr. Venkatesan has received research support from NIH. The institution of Dr. Venkatesan has received research support from U.S. DOD.
Taolin Fang, MD Dr. Fang has nothing to disclose.
Maranatha Ayodele, MD Dr. Ayodele has nothing to disclose.
Spencer Funk, DO Dr. Funk has nothing to disclose.
Jeannie J. Lee, MD Dr. Lee has nothing to disclose.
Michael M. Gezalian, MD Dr. Gezalian has nothing to disclose.
Shahed Toossi, MD Dr. Toossi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zoll, Inc. Dr. Toossi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various legal firms .
Sean McDougall, MD Dr. McDougall has nothing to disclose.
Shouri Lahiri, MD Dr. Lahiri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Lahiri has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medicolegal consultations.. Dr. Lahiri has stock in Prometheus. The institution of Dr. Lahiri has received research support from National Institutes of Health. The institution of Dr. Lahiri has received research support from F. Widjaja Foundation.
Jeffrey M. Chung, MD, FAAN Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Asvar Law. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Oak Crest Institute of Science.
Bharath Wootla No disclosure on file
Faten El Ammar, MD Dr. El Ammar has nothing to disclose.
Jared Davis No disclosure on file
Luis J. Meneses Quiroz, MD Dr. Meneses Quiroz has nothing to disclose.
Pareena Sharma Miss Sharma has nothing to disclose.
Julien Thomas, MD, MPH Dr. Thomas has nothing to disclose.
Reid Collis No disclosure on file
Philip Van Damme The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for QurAlis. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for VectorY. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NRG Therapeutics. The institution of Dr. Van Damme has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Van Damme has received research support from CSL Behring.
Azima Shaji, MD, MBBS Dr. Shaji has nothing to disclose.
Amanda Jagolino-Cole, MD, FAAN Dr. Jagolino-Cole has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生 - Neurology Clinical Practice Journal. .
Tamia Garrett, MS Miss Garrett has nothing to disclose.
Sushanth R. Aroor, MD Dr. Aroor has stock in Gravity.
Sishir Mannava, MD Dr. Mannava has nothing to disclose.
Tia Lal No disclosure on file
Ieshia Deal No disclosure on file
Sunita Devi No disclosure on file
Areeba Memon No disclosure on file
Abigail S. Betner, MLS Mrs. Betner has nothing to disclose.
Charles Green Charles Green has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University of Texas at Austin. Charles Green has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baylor College of Medicine. Charles Green has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Society of Research on Nicotine and Tobacco. Charles Green has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Society for Psychophysiology. The institution of Charles Green has received research support from NIH. The institution of Charles Green has received research support from DoD. The institution of Charles Green has received research support from VA. The institution of Charles Green has received research support from Michael J. Fox Foundation. The institution of Charles Green has received research support from American Association for Cancer Research.
Peter Y. Van Den Bergh, MD, PhD, FAAN Dr. Van den Bergh has nothing to disclose.
Lahoud Touma, MD Dr. Touma has nothing to disclose.
Danny Diep No disclosure on file
Filza Hussain No disclosure on file
Sumera Javed No disclosure on file
Christopher Medina, MD Dr. Medina has nothing to disclose.
Yakov Isakov, DO Dr. Isakov has nothing to disclose.
Amy Wen Ms. Wen has nothing to disclose.
Aimee Derry No disclosure on file
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Laxmi Shah, DO No disclosure on file
Dan Tong Jia, MD Dr. Jia has nothing to disclose.
Matthew Maas, MD, FAAN The institution of Dr. Maas has received research support from National Institutes of Health.
Elia Haddad, MD No disclosure on file
Henk-Andre A. Kroon, MD, MBA Dr. Kroon has received personal compensation for serving as an employee of Annexon Biosciences. Dr. Kroon has stock in Annexon Biosciences.
Zhahirul Islam Zhahirul Islam has nothing to disclose.
Kunal Kanani No disclosure on file
Eric Humphriss Eric Humphriss has received personal compensation for serving as an employee of Annexon Biosciences. Eric Humphriss has stock in Annexon Biosciences.
Preeti Paliwal No disclosure on file
Quazi Deen Mohammad, MD Dr. Deen Mohammad has nothing to disclose.
Colin Anderson-Smits No disclosure on file
James A French No disclosure on file
Shabbir Hasan Shabbir Hasan has received stock or an ownership interest from Takeda.
Erin Greco No disclosure on file
Hakan AY, MD Dr. AY has received personal compensation for serving as an employee of Takeda.
Milagros D. Pascual-Guevara Miss Pascual-Guevara has nothing to disclose.
Miguel F. Cabanillas Lazo Mr. Cabanillas Lazo has nothing to disclose.
Lisa K. Peterson, PhD Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Werfen. Dr. Peterson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Werfen. Dr. Peterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AliveDx. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Biochemistry. Dr. Peterson has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lab Q for ASCP. Dr. Peterson has a non-compensated relationship as a President with Association of Medical Laboratory Immunologists that is relevant to AAN interests or activities.
Kyphuong Luong No disclosure on file
Nikhil Khandelwal No disclosure on file
Sepehr Farahbakhshian No disclosure on file
Anne Loos No disclosure on file
Busayo Soyemi No disclosure on file
Sam Taylor No disclosure on file
Faisal Riaz, MD Dr. Riaz has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Riaz has stock in Takeda.
Yousef Aldughaythir, MD Dr. Aldughaythir has nothing to disclose.
Mohammed Alanazy, MD Dr. Alanazy has nothing to disclose.
Abdulrahman Ali No disclosure on file
Lawrence A. Zeidman, MD, FAAN Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zeidman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Smith Blake Hill LLC. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.
Sanita Raju, MD Dr. Raju has nothing to disclose.
Muhammad H. Jaffer, MD Dr. Jaffer has nothing to disclose.
Sepideh Mokhtari, MD Dr. Mokhtari has nothing to disclose.
Edwin N. Peguero, MD Dr. Peguero has nothing to disclose.
Ursula Boschert Shafaatian Ursula Boschert has nothing to disclose.
Anisha Garg, MD Dr. Garg has nothing to disclose.
Ryan Verity, MD Dr. Verity has nothing to disclose.
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Tammy Dellovade No disclosure on file
Joel Arackal No disclosure on file
Brett Venker No disclosure on file
Jingyu Wang No disclosure on file
Jennifer Schwinn Jennifer Schwinn has received personal compensation for serving as an employee of Immunovant, Inc..
Paola Mina-Osorio, MD, PhD Dr. Mina-Osorio has received personal compensation for serving as an employee of Immunovant. Dr. Mina-Osorio has stock in Immunovant, Inc..
Jason T. Schick, DO Dr. Schick has nothing to disclose.
Bradley Haveman-Gould, PA Mr. Haveman-Gould has nothing to disclose.
Christopher M. Goshgarian, MD Dr. Goshgarian has nothing to disclose.
OREOFE ADESINA No disclosure on file
Manuela Ochoa Urrea, MD Dr. Ochoa Urrea has nothing to disclose.
Hebatallah Rashed No disclosure on file
Kamal Shouman, MD Dr. Shouman has nothing to disclose.
Catarina Aragon Pinto, MD Dr. Aragon Pinto has nothing to disclose.
Marcus Vinicius R. Pinto, MD Dr. Pinto has nothing to disclose.
Peter J. Dyck, MD, FAAN Dr. Dyck has nothing to disclose.
JaNean Engelstad JaNean Engelstad has nothing to disclose.
P. James B. Dyck, MD, FAAN Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Catherine Daley, MD Dr. Daley has nothing to disclose.
Frederic Bernard No disclosure on file
Iqra Faiz Miss Faiz has nothing to disclose.
Kayla Scippa No disclosure on file
Sheryl Pease Sheryl Pease has received personal compensation for serving as an employee of Johnson & Johnson. Sheryl Pease has received personal compensation for serving as an employee of Pfizer.
Lisa M. Ford, MD, FAAN Dr. Ford has received personal compensation for serving as an employee of Janssen . Dr. Ford has stock in Janssen.
Alberto Batista No disclosure on file
Jake Macey No disclosure on file
Sarah Knight No disclosure on file
Hannah Edge No disclosure on file
Elizabeth Collins No disclosure on file
Janice Wong, MD Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Anabella Frances, MD Dr. Frances has nothing to disclose.
Andres Ignacio Berardo Andres Ignacio Berardo has nothing to disclose.
Ignacio Bozas, MD Dr. Bozas has nothing to disclose.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Albert Saiz Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janseen. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Albert Saiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Karandeep S. Bhatti, MBBS Dr. Bhatti has nothing to disclose.
Pinar Kahraman Koytak, MD Dr. Kahraman Koytak has nothing to disclose.
Kayihan Uluc, MD Dr. Uluc has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer.
Beyza A. Arslan, MD Dr. Arslan has nothing to disclose.
Antonio Cano No disclosure on file
Elham Askari, MD Dr. Askari has received personal compensation for serving as an employee of Stony Brook Hospital University.
Razia Sultana Ms. Sultana has nothing to disclose.
Nicole Zhao Miss Zhao has nothing to disclose.
Claire P. Polizu Ms. Polizu has nothing to disclose.
Simona Treidler, MD Dr. Treidler has nothing to disclose.
Pierre Clavelou, MD, PhD Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Alisha Qaiser, MD Dr. Qaiser has nothing to disclose.
Kamalpreet K. Mann, MD Dr. Mann has nothing to disclose.
Ronel Santos No disclosure on file
Christopher Morgan, MD Dr. Morgan has nothing to disclose.
Soumya Madala No disclosure on file
Albert D. Ho, MD Dr. Ho has nothing to disclose.
Susan M. Woolner, CPXP Ms. Woolner has nothing to disclose.
Aileen Antonio, MD, FAAN Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cochrane. An immediate family member of Dr. Antonio has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Giamarco, Mullins & Horton PC. The institution of Dr. Antonio has received research support from Saint Mary's Foundation. Dr. Antonio has received research support from 好色先生.
Elijah Mak No disclosure on file
Dheeraj D. Lalwani Mr. Lalwani has nothing to disclose.
Julia Zabinska Ms. Zabinska has nothing to disclose.
Rachel Forman, MD Dr. Forman has nothing to disclose.
Emma S. Peasley Miss Peasley has nothing to disclose.
Jacqueline Geer No disclosure on file
Anna Schwartz No disclosure on file
Guido J. Falcone, MD The institution of Dr. Falcone has received research support from NIH. The institution of Dr. Falcone has received research support from AHA.
Lauren H. Sansing, MD Dr. Sansing has nothing to disclose.
Rohan Arora, MD The institution of Dr. Arora has received research support from Bayer.
Carlos Mena-Hurtado Carlos Mena-Hurtado has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Terumo. Carlos Mena-Hurtado has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BD. Carlos Mena-Hurtado has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert witness. The institution of Carlos Mena-Hurtado has received research support from Shockwave.
Adam De Havenon, MD, FAAN Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Munachi N. Okpala, NP Ms. Okpala has nothing to disclose.
Cheryl Bushnell, MD, MHS The institution of Dr. Bushnell has received research support from PCORI. The institution of Dr. Bushnell has received research support from NIH/NINDS. Dr. Bushnell has received intellectual property interests from a discovery or technology relating to health care. Dr. Bushnell has received publishing royalties from a publication relating to health care.
Michael T. Mullen, MD Dr. Mullen has received publishing royalties from a publication relating to health care.
Jordana Cohen Jordana Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Jordana Cohen has received research support from National Institutes of Health. Jordana Cohen has received publishing royalties from a publication relating to health care.
Debbie Cohen Debbie Cohen has nothing to disclose.
Steven R. Messe, MD, FAHA, FAAN Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Terumo. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for WL Gore. The institution of Dr. Messe has received research support from WL Gore. The institution of Dr. Messe has received research support from Mallinkrodt. The institution of Dr. Messe has received research support from Biogen. Dr. Messe has received intellectual property interests from a discovery or technology relating to health care. Dr. Messe has received publishing royalties from a publication relating to health care. Dr. Messe has received personal compensation in the range of $500-$4,999 for serving as a Clinical Event Committee for the CONFORMAL left atrial appendage occlusion trial with Yale Cardiovascular Research Group.
Kevin N. Sheth, MD, FAAN Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Dong-Ick Shin, MD, PhD Dong-Ick Shin, MD, PhD has nothing to disclose.
Ho-seong Han Ho-seong Han has nothing to disclose.
David Gozal No disclosure on file
Hans Van Dongen Hans Van Dongen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceuticals. Hans Van Dongen has received intellectual property interests from a discovery or technology relating to health care. Hans Van Dongen has received publishing royalties from a publication relating to health care.
Eileen Leary, PhD Dr. Leary has received personal compensation for serving as an employee of Centessa Pharmaceuticals. Dr. Leary has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Partners Group. Dr. Leary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulse Infoframe. Dr. Leary has or had stock in Jazz Pharmaceuticals.Dr. Leary has or had stock in Axsome Therapeutics.Dr. Leary has or had stock in Centessa Pharmaceuticals.
Gregory S. Parks, PhD Dr. Parks has received personal compensation for serving as an employee of Axsome Therapeutics. Dr. Parks has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Parks has stock in Axsome Therapeutics. Dr. Parks has stock in Jazz Pharmaceuticals.
Samantha Floam, DMD Dr. Floam has received personal compensation for serving as an employee of Axsome Therapeutics.
Herriot Tabuteau Herriot Tabuteau has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Axsome Therapeutics.
Carlos A. Rodríguez Alarcón, MD Dr. Rodríguez Alarcón has nothing to disclose.
Linker E. Viñan Paucar, Sr. Mr. Viñan Paucar has nothing to disclose.
Danny J. Japon Mr. Japon has nothing to disclose.
Michelle Hidalgo De La Cruz No disclosure on file
Presley M. Gruezo, Jr. Mr. Gruezo has nothing to disclose.
Ricardo J. Moran Mr. Moran has nothing to disclose.
Rocio A. Santibanez, MD, FAAN Dr. Santibanez has nothing to disclose.
Louis C. Tan, MRCP No disclosure on file
Christian F. Mouchati, MD Dr. Mouchati has nothing to disclose.
Irene L. Katzan, MD Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Maeve M. Pascoe, MD Ms. Pascoe has nothing to disclose.
Harneet Walia No disclosure on file
Laura Mora Munoz, MD Dr. Mora Munoz has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Joyce A. Jimenez Zambrano, MD Dr. Jimenez Zambrano has nothing to disclose.
Elisa S. Chaw Miss Chaw has nothing to disclose.
Alexander C. Noritz Mr. Noritz has nothing to disclose.
Dennise Tatiana T. Freire Jiménez Dr. Freire Jiménez has nothing to disclose.
Andrea C. Vera Miss Vera has nothing to disclose.
Maria J. Cueva Espinoza Ms. Cueva Espinoza has nothing to disclose.
Simone M. Munoz, Sr. Miss Munoz has nothing to disclose.
Natalia Borja Delgado No disclosure on file
Romina F. Cedeno Morejon Miss Cedeno Morejon has nothing to disclose.
Luis Yepez Luis Yepez has nothing to disclose.
Nagaendran Kandiah, MD No disclosure on file
Christina Marini Ms. Marini has nothing to disclose.
Julia Greenberg, MD Dr. Greenberg has a non-compensated relationship as a Editorial Board Member with Neurology Resident and Fellow Section that is relevant to AAN interests or activities.
Sophia T. Tong Ms. Tong has nothing to disclose.
Kiril Kiprovski, MD Dr. Kiprovski has nothing to disclose.
Azizi Seixas No disclosure on file
Lisa Doan No disclosure on file
Ricardo Osorio No disclosure on file
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Laura J. Balcer, MD, MSCE, FAAN An immediate family member of Dr. Balcer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Children's Hospital of Philadelphia.
Maha Alattar, MD Dr. Alattar has nothing to disclose.
Shraddha Mainali, MD Dr. Mainali has received personal compensation for serving as an employee of Virginia commonwealth University.
Alok Govind No disclosure on file
Yaroslav Winter Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angelini Pharma. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia Pharmaceuticals. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for JAZZ Pharmaceuticals. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Prof. Winter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Presisis.
Geert K. Mayer, MD, PhD Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen, Idorsia, NLS Pharma. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia, Takeda. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia.
Heike Benes No disclosure on file
Lothar Burghaus No disclosure on file
Iresha Abeynayake Iresha Abeynayake has received personal compensation for serving as an employee of Axsome. Iresha Abeynayake has stock in Axsome.
Hannah Kwak No disclosure on file
Ulf Kallweit Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bioprojet. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bioprojet. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bioprojet. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmanovia. Ulf Kallweit has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Juan Jose Martin Juan Jose Martin has nothing to disclose.
Maria Alvarez Bollea No disclosure on file
Dwight Barry No disclosure on file
Catherine M. Amlie-Lefond, MD, FAAN Dr. Amlie-Lefond has nothing to disclose.
Kristin Maher No disclosure on file
Saloni Behl Saloni Behl has nothing to disclose.
Jyoti Aggarwal No disclosure on file
Nanco Hefting No disclosure on file
Dalei Chen No disclosure on file
Denise Chang No disclosure on file
Daniel Lee No disclosure on file
Jesse Thon, MD An immediate family member of Dr. Thon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. An immediate family member of Dr. Thon has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech.
Tom T. Noff, MD Dr. Noff has nothing to disclose.
Steven T. Whitworth, PhD Dr. Whitworth has received personal compensation for serving as an employee of Neurelis Inc..
Mohammed Alnafisah, MBBS Dr. Alnafisah has nothing to disclose.
Stephanie M. Varjan No disclosure on file
Jeanne A. Vander Zanden, PharmD, BCPP Dr. Vander Zanden has nothing to disclose.
Alyssa Jameson, PA Ms. Jameson has nothing to disclose.
Jessica Cirillo Mrs. Cirillo has received personal compensation for serving as an employee of Pfizer. Mrs. Cirillo has stock in Pfizer.
David Semel David Semel has received personal compensation for serving as an employee of pfizer.
Zahid Iqbal, MD Dr. Iqbal has nothing to disclose.
Rufida A. Salih, MBBS Dr. Salih has nothing to disclose.
Sanjeda Chumki No disclosure on file
Anuraag Gattu Mr. Gattu has nothing to disclose.
Ana Maria Roman, MD Dr. Roman has nothing to disclose.